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 7 Summary 
Summary 
Magnetic resonance imaging has become a powerful tool in both clinical and preclinical 
research to non-invasively assess brain structure and function. Its application to animals has 
opened new possibilities to perform longitudinal studies in order to investigate anatomical or 
functional plasticity of the brain e.g. after injuries of the nervous system. Functional MRI 
(fMRI) allows assessing activation of brain areas in response to a stimulus by measuring local 
changes of the vascular system associated with neuronal activation. fMRI is also playing an 
important role in pain research. Chronic pain is a major issue in our society and much 
research is done in order to reveal its underlying mechanisms and develop potent new drugs. 
(Functional) MRI provides a way to assess the network of brain areas involved in pain 
perception and processing, and to reveal potential changes associated with pathological pain. 
The method, originally applied in human studies, has been translated back to small animals, 
which allows performing basic research on animal models of different pain pathologies. Most 
of these studies have been performed in rats. In view of the many transgenic mouse lines 
available it would be advantageous to transfer the method to mice.  
The establishment of mouse fMRI to assess sensory and nociceptive processing by measuring 
changes in blood oxygenation (BOLD, blood oxygen level dependent contrast) was one of 
the main goals of this thesis. In a first study described in Chapter 2, an electrical forepaw 
stimulation paradigm was implemented. The resulting changes in BOLD signal were assessed 
using a cryogenically cooled radiofrequency (RF) coil (CryoProbe) in a small-animal 9.4 T 
system. BOLD signal changes in response to four different stimulation amplitudes were 
measured using a gradient-echo echo-planar imaging (GE-EPI) sequence. The signal changes 
observed correlated well with the stimulation amplitude and were located in the brain areas 
associated with somatosensory and nociceptive processing. The BOLD signals were analyzed 
in terms of amplitude and signal decay to better understand the signal dynamics and its 
underlying mechanisms.  
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The forepaw stimulation paradigm has been used to assess the performance of the CryoProbe 
in comparison with a conventional room temperature (RT) coil for fMRI applications. The 
use of the CryoProbe yielded a gain in signal-to-noise ratio (SNR) as compared with the RT 
coil. This gain in sensitivity allows acquiring sequences with high spatial and temporal 
resolution, which are important prerequisites in small animal imaging. In addition to the 
comparison in terms of sensitivity, the influence of different shield surface temperatures on 
the BOLD signal and the cerebral blood volume (CBV) was investigated. The heated ceramic 
shield of the CryoProbe protects the mouse head from the cooled RF coil and can be 
adjusted to different temperatures. Four different temperatures in the range of 22-38 °C were 
analyzed and found to significantly influence baseline CBV and stimulus-induced BOLD 
signal changes. 
The electrical stimulation paradigm was then applied to pharmacologically pretreated mice. 
The animals received forepaw injections of very low concentrations of the local anesthetic 
lidocaine prior to electrical stimulation. This pretreatment led to an increase in BOLD signal 
changes as compared with untreated mice. The detailed mechanisms of the lidocaine-induced 
hyperalgesia still remain unclear, but experiments using global cannabinoid-receptor 1 (CB1) 
knock-out mice or a CB1-blocking drug in wild type animals suggest an involvement of the 
CB1 receptor.  
Another application used electrical stimulation to investigate nociceptor-specific NaV1.7R-/- 
mice. These mice are lacking a sodium channel important for the propagation of action 
potentials in nociceptors, leading to insensitivity to noxious stimuli. In the fMRI experiment, 
this led to a significant decrease of the BOLD signal in response to electrical stimulation as 
compared with wild type mice.     
As electrical stimulation may not always be suitable to assess nociceptive processing due to 
reasons outlined in Chapter 6, we aimed at developing a strictly nociceptive stimulation. 
High (noxious) temperatures activate specific thermoreceptors located on C-fiber sensory 
afferents, rendering it a true physiological stimulus. The heat stimulation paradigm using 
infrared laser diodes with a temperature-controlling feedback loop was tested for 45 and 46 
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°C. Specificity of the paradigm for nociceptive signaling was demonstrated by 
pharmacological modulation of the response via TRPV1 receptor-mediated blockage of 
sodium channels. Combined administration of the TRPV1 agonist capsaicin and the 
lidocaine derivative QX-314 has been shown to induce a C-fiber specific block, inhibiting 
the transmission of activation elicited by noxious heat stimulation. In the fMRI experiments 
using thermal stimulation, this pretreatment led to an abolishment of the BOLD signal, 
demonstrating the nociceptive-specific action of the stimulation paradigm.  
In summary, two stimulation paradigms to assess processing of innocuous and/or noxious 
peripheral input in mice using BOLD fMRI have been established. Both paradigms have 
been validated and applied to different models. The application of the CryoProbe allowed for 
sufficiently high SNR, temporal and spatial resolution to detect BOLD changes of a few 
percent in very small brain areas. This provides a tool for different applications to investigate 
pain processing in mouse models of different pain pathologies. The non-invasive nature of 
the method allows for longitudinal studies to follow changes in structure and/or function of 
the brain over time.   
 10 Zusammenfassung 
Zusammenfassung 
Kernspintomographie (magnetic resonance imaging, MRI) ist ein modernes bildgebendes 
Verfahren, das eine immer wichtigere Rolle in der Diagnostik sowie in der klinischen und 
präklinischen Forschung spielt. Mittels starken Magnetfeldern und Radiofrequenz-Wellen 
werden magnetische Eigenschaften von Materie, z.B. von Wasser im Gewebe, erfasst, was die 
nicht invasive Untersuchung von Struktur und Funktion des Gehirns oder anderer Organe 
ermöglicht. Die Übertragung der Technik auf Tierexperimente eröffnet neue Möglichkeiten 
im Bereich der Grundlagenforschung. Sie erlaubt es, Veränderungen in Struktur oder 
Funktion des Gehirns z.B. nach Verletzungen des Nervensystems über längere Zeit im 
gleichen Tier zu verfolgen. Neuronale Aktivität im Gehirn kann mittels funktionellem MRI 
(fMRI) gemessen werden. Dabei werden lokale Änderungen des vaskulären Systems, die im 
Zusammenhang mit neuronaler Aktivierung stehen, gemessen. In der Schmerzforschung 
spielt fMRI eine wichtige Rolle, da es erlaubt, das Netzwerk von Hirnstrukturen, die durch 
einen Schmerzreiz aktiviert werden, zu ermitteln. Chronischer Schmerz ist ein medizinisches 
Problem von zunehmender Bedeutung unserer Gesellschaft, wobei es für viele pathologische 
Schmerzen noch keine zufriedenstellende Therapie gibt. Intensive Forschung bemüht sich, 
die Mechanismen, die für die pathologischen Schmerzen verantwortlich sind, aufzuklären 
und wirksame Medikamente mit geringen Nebenwirkungen dagegen zu entwickeln. 
(Funktionelles) MRI wird dabei eingesetzt, um mögliche Veränderungen der Hirnstruktur 
oder –funktion, die bei chronischen Schmerzen auftreten können, zu messen. Die 
Anwendung der Methode bei Kleintieren erlaubt es, Grundlagenforschung an verschiedenen 
Modellen für krankhafte Schmerzleiden zu betreiben. Bis jetzt wurden die meisten Studien 
an Ratten durchgeführt. Die Übertragung der Methoden auf die Maus wäre jedoch wichtig, 
um einen Nutzen aus den zahlreichen transgenen Mausmodellen zu ziehen.  
Eines der Hauptziele dieser Arbeit bestand darin, ein zuverlässiges Stimulationsparadigma zu 
entwickeln, um damit die Schmerzverarbeitung in der Maus zu untersuchen. In einer ersten 
Studie stimulierten wir die Vorderpfote der Maus elektrisch. Die davon ausgelöste Aktivität 
im Hirn wurde über Änderungen der Blutoxygenierung (blood oxygen level dependent 
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contrast, BOLD) in einem MRI System mit 9.4 T Magnetfeldstärke gemessen. Um die 
Sensitivität zu steigern, wurde eine Tieftemperatur-Radiofrequenzspule (CryoProbe) 
verwendet. Die durch die Stimulation ausgelösten BOLD-Signaländerungen in den 
aktivierten Regionen korrelierten stark mit den verwendeten Stromstärken; die stärkste 
Stimulation löste die grösste Signaländerung aus. Die Signale traten zudem in den 
Hirnarealen auf, die bekannterweise in die Schmerzverarbeitung involviert sind. Um die 
Dynamik des Signals besser zu verstehen, wurde der zeitliche Verlauf der BOLD-
Signaländerungen bezüglich der maximalen Amplitude und des Signalzerfalls analysiert. 
Das entwickelte Stimulationsparadigma wurde gebraucht, um die Detektionsempfindlichkeit 
der CryoProbe mit der einer konventionellen Raumtemperatur-Spule zu vergleichen. In 
diesen Experimenten zeigte die CryoProbe eine wesentlich höhere Sensitivität, die mit einem 
besseren Signal zu Rauschen-Verhältnis einherging. Die erhöhte Sensitivität konnte 
eingesetzt werden, um die räumliche und zeitliche Auflösung im Vergleich zu der 
Raumtemperatur-Spule zu steigern, was bei Mausstudien von erheblichem Vorteil ist.  
Die elektrische Stimulation wurde angewendet, um den Effekt von pharmakologischen 
Interventionen auf die Signaltransmission zu untersuchen. Den Mäusen wurde vor der 
Stimulation ein Lokalanästhetikum (Lidocain) in geringer Konzentration in die Pfote 
gespritzt. Entgegen der Erwartung führte dies zu einer erhöhten BOLD-Signaländerung, was 
auf eine Hyperalgesie (übermässiges Schmerzempfinden) hinweist. Die genauen 
Mechanismen, die zu dieser Hyperalgesie führten, sind noch nicht geklärt. Experimente mit 
Mäusen, denen der Cannabinoidrezeptor 1 (CB1) fehlt, sowie Experimente, bei denen der 
CB1-Rezeptor pharmakologisch blockiert wurde, lassen darauf schliessen, dass der CB1-
Rezeptor dabei eine Rolle spielt.  
Genetisch veränderte Mäuse, bei denen die Expression eines Natriumkanals auf den 
Schmerzrezeptoren unterdrückt wurde, verspüren keinen Schmerz. Das Fehlen des Kanals 
hat zur Folge, dass die Signale nicht via Aktionspotenzial zu höheren Zentren der 
Schmerzmatrix weitergeleitet werden. In den fMRI Experimenten zeigten die genetisch 
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veränderten Mäuse eine verminderte BOLD Signaländerung als Reaktion auf die elektrische 
Stimulation. Diese Resultate bestätigen die Relevanz des elektrischen Stimulationsparadigma.   
Da die elektrische Stimulation aus verschiedenen Gründen (s. Kapitel 6) nicht für alle 
Schmerzstudien geeignet ist, wurde eine thermische Stimulation entwickelt. Hohe 
Temperaturen aktivieren direkt Thermorezeptoren, die sich auf so genannten C-Fasern 
befinden. Dadurch erhält man einen physiologischen Stimulus. Die hohen Temperaturen 
wurden mit einem auf die Vorderpfoten gerichteten Laserstrahl erzielt und über ein 
automatisches Regelsystem kontrolliert. Die Stimulation wurde bei 45 und 46 °C 
durchgeführt und ihre Spezifität pharmakologisch getestet. Frühere Studien haben gezeigt, 
dass Capsaicin, ein Agonist der TRPV1-Rezeptoren, zusammen mit dem Lidocainderivat 
QX-314 spezifisch die C-Fasern hemmt. Die aktivierten und  geöffneten TRPV1-Rezeptoren 
ermöglichen das Eindringen von QX-314 in die Zellen, wo es die Natriumkanäle blockiert. 
In der fMRI-Studie brachte die Verabreichung der zwei Substanzen die BOLD-
Signaländerung zum Verschwinden, was bestätigt, dass durch die thermale Stimulation 
spezifisch die C-Fasern aktiviert werden. 
In der vorliegenden Arbeit wurden zwei Stimulationsparadigmen entwickelt, die es erlauben, 
Schmerzverarbeitung bei Mäusen mittels fMRI zu untersuchen. Beide Stimulationen wurden 
validiert und für unterschiedliche Modelle angewendet. Durch die Verwendung der 
CryoProbe waren die Messungen genügend sensitiv, um Signaländerungen von nur wenigen 
Prozenten in kleinen Hirnarealen zu messen.      
 13 1.1 Magnetic Resonance Imaging (MRI) 
1. Introduction 
1.1 Magnetic Resonance Imaging (MRI) 
Historical Overview 
Magnetic resonance imaging (MRI) is a relatively new imaging technique which founds on 
the independent discovery of the nuclear magnetic resonance phenomenon by Edward 
Purcell (Harvard University) and Felix Bloch (Stanford University) in 1946 [1, 2]. This 
discovery led to the development of NMR spectroscopy, which soon became an important 
method to study the structure of chemical compounds. Bloch and Purcell were awarded the 
Nobel Prize in Physics in 1952.  
In 1966, Richard Ernst found a way to increase the sensitivity of NMR by replacing the 
traditionally used slow passage NMR of sweeping a radiofrequency wave across the spectrum, 
by Fourier NMR using short intense pulses [3]. A few years later, Ernst developed a 
technique that enabled high resolution, two-dimensional NMR spectroscopy of large 
molecules. For his achievements in NMR, Richard Ernst was awarded the Nobel Prize in 
Chemistry in 1991.  
Around the same time, Paul Lauterbur moved from the single dimension of NMR 
spectroscopy to two-dimensional first MR images by introducing gradients into the magnetic 
field, allowing deriving spatial information about an object [4]. Sir Peter Mansfield then 
further processed the applications of gradients in the magnetic field. He also developed a way 
to mathematically analyze the MR signals which enabled fast generation of images based on 
the MR signal [5]. Following this, he developed the echo-planar-imaging technique (EPI), 
which allowed fast image acquisition and is still frequently used in today’s research. 
Lauterbur and Mansfield received the Nobel Prize in Physiology or Medicine in 2003. 
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It was not until 1992, when functional MRI (fMRI) was developed [6, 7], a technique 
abundantly used nowadays both in research and medical diagnostics, allowing assessing the 
function of various regions of the brain.  
Imaging Modalities 
Today, MRI is an indispensable tool in diagnostics and biomedical research in both humans 
and animals. It is one of many non-invasive imaging modalities available, each of it with its 
advantages and disadvantages. The oldest biomedical imaging technique is X-ray imaging, 
which was further developed into computed-tomography (CT), the first modality to give 
high resolution and 3D images from inside a body. Due to its relatively low costs, high tissue 
contrast for fat, lean mass and bones, and high spatial resolution, it is one of the most 
popular imaging modalities used, despite its harmful ionizing radiation. Another imaging 
technique is positron emission tomography (PET), which detects radioactively labeled tracers 
that are incorporated into a biologically active molecule, diffuse through tissue or bind to a 
specific target. Despite the relatively poor spatial resolution, PET is a frequently used 
diagnostic tool, particularly in cancer diagnostics. The highly specific tracer-target interaction 
yields a high sensitivity. MRI was first known and used for its high soft tissue contrast. Due 
to the different properties of different tissues, the contrast can be adapted for best display of 
the target tissue. However, the technique has developed tremendously over the past 20 years, 
allowing not only to obtain anatomical and structural information of different parts of the 
body, but also providing information about (brain) function (fMRI), the vascular system 
(angiography), tissue perfusion (perfusion MRI), blood or tissue oxygenation (BOLD fMRI), 
diffusion tensor imaging (DTI) for measuring diffusion and depicting fiber tracts, and 
differences of tissue elasticity (MR elastography). Continuing research will contribute to 
further development of new techniques and refinement of existing techniques. In MRI, 
patients are not subjected to harmful radiation or substances; instead they are placed in a 
strong static magnetic field.    
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Basic Principles of MRI  
The underlying physical property of the NMR and MRI technique is the nuclear magnetic 
resonance phenomenon. It describes the property of some nuclei, which, when placed in a 
magnetic field, may absorb energy from an applied electromagnetic pulse in the 
radiofrequency range and re-emit this energy at a specific resonance frequency in order to 
return back to the original energy state. This phenomenon is based on quantum physics 
principles, but the basics can also be explained by classical physics. 
Every atomic nucleus is composed of small positively charged particles called protons and 
neutral particles called neutrons. Nuclei with odd proton and/or neutron numbers possess a 
property called ‘nuclear spin’ or simply ‘spin’, which can be imagined as a rotation around an 
axis with a certain frequency. The nuclear spin is associated with a magnetic moment, i.e. the 
nuclei behave like tiny magnets. The most abundant nuclear species possessing a spin is the 
hydrogen nucleus consisting of one proton only. When placed within a static magnetic field 
B0, the spins align in the direction of the magnetic field. However, some will align with the 
field (parallel), while some align against the field (antiparallel), which corresponds to two 
different energy states. The magnetic moments of the protons in the different states will 
cancel each other out, nevertheless, a slight excess (approx. 10-6 at 1 T and 37 °C) will align 
with the B0 field, leading to a net magnetization called longitudinal magnetization. The 
excess number of parallel protons increases proportional with increasing B0.  
All spins regardless of their energy state precess around the axis of the B0 field with a certain 
frequency, which is proportional to B0 and can be described by the Larmor equation:  
𝜔∅ =  𝛾 ∙  𝐵0 
ω0 [Hz, MHz] is the Larmor or resonance frequency, B0 [Tesla, T] the strength of the static 
magnetic field and γ the gyromagnetic ratio, a constant unique to every atom. For protons, 
the gyromagnetic ratio is 42.5 MHz/T.   
Longitudinal magnetization cannot be measured by the receiver coils as it is aligned parallel 
to the B0 field; to become measurable, the magnetization in z-direction needs to be forced 
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into the x-y-plane, where it precesses around the static field. This is accomplished by exciting 
the spins using a radiofrequency (RF) pulse at the resonance frequency. They absorb the 
energy and change to the higher energy level, corresponding to the antiparallel state, leading 
to a decrease of the net longitudinal magnetization due to a cancelling-out effect. In addition, 
the RF pulse synchronizes the spins in a way that they start to precess in phase around the 
static magnetic field, leading to a transverse magnetization vector oriented perpendicular to 
the B0 field. The transverse magnetization induces an electrical current in a detector coil, 
resulting in the MR signal.  
Once the RF transmitter is switched off, exponential recovery of longitudinal magnetization 
and exponential decay of transverse magnetization occur. These processes are commonly 
described as the following relaxation processes: 
1) T1 (spin-lattice) relaxation: T1 refers to a time characteristic for the spins to realign with 
the z-axis, returning to the lower energy level (parallel state). As the spins do not realign 
simultaneously, longitudinal magnetization increases gradually. The energy released by this 
process is transferred to the surrounding tissue (lattice), reestablishing thermal equilibrium. 
The T1 value is characteristic for different kinds of tissue, and depends on the B0 field 
strength.  
 
Figure 1-1: Relaxation rates of longitudinal magnetization (1/T1) and transverse magnetization (1/T2). 
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2) T2 (spin-spin) relaxation: Interactions between neighboring spins and fluctuating 
changes in magnetic susceptibility lead to dephasing of the spins, inducing a decrease of 
transverse magnetization, resulting in an overall signal loss. The T2 value is unique for every 
kind of tissue and determined predominantly by its chemical environment, while it is largely 
independent of the magnetic field strength. However, in reality, the transverse magnetization 
decays much faster than described by T2. The faster decay is due to inhomogeneities of the 
main magnetic field, which may be produced by the measured tissue placed within the field. 
This relaxation rate, which is a more accurate measure of the signal decay, is named T2*.   
The spatial information of an object is obtained by applying gradient fields to the B0 field. 
The frequency encoding gradient leads to small differences in the strength of the magnetic 
field as a function of the position, hence changing the precession frequencies of the spins at 
different locations. Depending on their position, they will therefore emit signals at different 
frequencies. A second gradient, called phase-encoding gradient, applied perpendicular to the 
frequency encoding gradient, brings the spins that precess with the same frequency, out of 
phase, the phase shift depending on their location in the second dimension. Multiple values 
of the phase encoding gradient are required to record an image. These doubly encoded 
signals are mathematically processed by Fourier transformation, which analyzes the signals 
with regard to frequency and phase, allowing the allocation of the signal intensity at specific 
locations in two dimensions, allowing for reconstruction of the image [8, 9].  
Not only protons can be used for imaging, but any nucleus that possesses a spin and contains 
an odd number of protons and/or neutrons. However, protons (hydrogen nuclei) are most 
suitable for MRI since hydrogen is very abundant throughout the body, and it has one of the 
highest gyromagnetic ratios of all nuclei, i.e. yielding a high sensitivity per nucleus. 
Nevertheless, a lot of research is also carried out on non-proton NMR.   
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1.2 functional MRI 
Functional MRI (fMRI) allows going beyond anatomical imaging by assessing physiological 
functions of the body, including e.g. dynamic cardiac imaging or perfusion imaging. In 
general, however, fMRI refers to measurements of local brain activation as a response to some 
kind of stimulus.   
Physical and Physiological Background 
Functional readouts are based on a process called neurovascular coupling, which describes the 
close coupling between neurons, astrocytes and the cerebrovascular system. Despite the 
relatively small size of the brain (2 %) compared to the rest of the body, it dissipates 20 % of 
total body oxygen and 25 % of total body glucose consumption. Neuronal activation, which 
comprises electrical signal transmission within the cell and chemical signal transmission 
between the cells, requires energy. As neurons are highly specialized cells, they cannot store 
glucose, therefore rely on external supply of glucose and oxygen. 
 
Figure 1-2: The neurovascular unit. Capillaries deliver oxygen and glucose to the neurons via the 
astrocytes. Changes in neuronal activity lead to increased cerebral blood flow and volume, which can 
be assessed by functional imaging. Adapted from [10]. 
 19 1.2 functional MRI 
 This renders the central principle underlying the functional imaging techniques, which 
visualize local changes in brain activity by measuring changes in blood flow and energy 
metabolism (i.e. hemodynamic response) [11]. Therefore, these imaging techniques only 
provide an indirect readout of the local brain activity by measuring a linked physiological or 
metabolic process. The exact association between neuronal activation and changes in blood 
flow and energy metabolism are still not fully understood (for review and controversial points 
see: [12-15]).  
Cerebral Blood Flow (CBF)  
The basic functions of CBF regulation and thus neurovascular coupling was proposed by Roy 
and Sherrington in 1890, postulating a local increase in CBF as a response to neuronal 
activation [16]. CBF delivers glucose and oxygen used for local energy metabolism and 
transports CO2 away from the cells. It is controlled by regulation of microcirculation and 
changes accordingly, in order to adapt to the varying demands of energy and oxygen by the 
neurons. CBF can be assessed by two different methods using fMRI: arterial spin labeling 
(ASL) and bolus tracking. Bolus tracking requires the intravenous administration of a 
contrast agent (CA), of which the first passage through the vascular system is analyzed to 
yield information about local blood flow values [17]. ASL does not require the application of 
an exogenous CA; instead the blood magnetization is changed at a specific point of an artery, 
inducing a change in signal intensity in the measurement located downstream of the labeling 
site, which is directly proportional to the blood flow. This procedure provides a repeatable, 
completely non-invasive technique for assessing CBF [18].  
Cerebral Blood Volume (CBV) 
Increases in CBV are also associated with neuronal activity and are usually assessed by 
injection of an exogenous CA, generally based on iron-oxide particles. Iron-oxide based CAs 
induce local inhomogeneities of the magnetic field, leading to a drop of signal in T2-weighted 
images. After injection of the CA, it will recirculate in the vascular system; after a while, 
depending on the distribution volume and the clearance rate, its concentration will reach a 
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steady state, i.e. will change only very slowly over time. Hence, any change in signal intensity 
can be attributed to a change in the local blood volume, rather than to a change in CA 
concentration. At steady state, a baseline measurement is acquired before applying a stimulus 
which will lead to local changes in CBV. With increasing CBV, the amount of CA increases 
in this area, yielding a decrease in signal intensity. CBV measurements are popular to assess 
brain function in animals [19-25]. However, the method is not in clinical use due to the lack 
of approval of the CAs for this application by the regulatory authorities.  
Blood Oxygenation Level Dependent (BOLD) Contrast 
BOLD contrast, first described by Ogawa et al., is based on deoxygenated hemoglobin (dHb) 
as an endogenous CA [26]. In 1936, Pauling discovered the paramagnetic properties of dHb, 
in contrast to the diamagnetic properties of oxygenated hemoglobin (Hb)[27]. Paramagnetic 
substances such as dHb induce local field inhomogeneities, which lead to susceptibility 
differences between the dHb-containing compartments and the surrounding tissue. The 
inhomogeneities induce dephasing of the spins, shortening the T2 relaxation time and leading 
to faster signal decay. Diamagnetic substances on the other hand (i.e. Hb), do not influence 
the signal decay. Upon neuronal activation, there is an increase of CBF, which exceeds the 
demands by the increased cerebral metabolic rate of oxygen (CMRO2). This mismatch leads 
to an increase in blood oxygenation at the veins and capillaries. A decrease in the relative 
dHb concentration reduces field inhomogeneities and dephasing, leading to an increase of 
the MR signal intensity. BOLD fMRI sequences are T2*-weighted, designed to pick up the 
BOLD signal increase as a response to neural activation.  
Two years after Ogawa’s discovery, the first functional studies were published, using dHb as 
an endogenous contrast agent [6, 7]. This introduced a new area of functional imaging, and 
today, BOLD fMRI is probably the most frequently used method for functional brain 
mapping in both humans and animals. BOLD fMRI is relatively easy to implement and does 
not depend on exogenous contrast agents. For more detailed information and reviews see 
[28-30].  
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1.3 fMRI in Small Animals 
Sensitivity  
The development of high-field MR systems has made this technique available for small 
animal research. Higher B0 field strengths are one of several ways to increase the signal-to-
noise ratio (SNR) needed in order to image small animals, usually one order of magnitude 
smaller than humans, with sufficiently high spatial and temporal resolution [31]. However, 
moving to higher field strengths increases T1 relaxation times while T2 and T2* relaxation 
times decrease, which may lead to longer acquisition times. In addition, susceptibility 
artifacts will appear more often and profoundly. Alternative methods to improve SNR such 
as increasing the voxel size or data averaging will impair spatial or temporal resolution.  
A different strategy to increase the SNR is lowering the noise level instead of increasing the 
signal. Noise in fMRI can have three sources: i) physiological noise, which originates from 
the subject, ii) thermal noise coming from the receiver electronics, and iii) static sample 
noise. For human fMRI at field strengths of 3 T and higher, physiological noise is the largest 
contributor to the total noise [32-34]. However; in small animal fMRI, the sum of static and 
physiological noise is of comparable order as the noise from the receiver electronics. 
Therefore, a successful approach to increasing the SNR was the development of cryogenically 
cooled RF coils [35, 36]. All studies in this thesis were therefore conducted using a prototype 
400 MHz cryogenic RF probe, operating at a temperature of 30 K, which today is 
commercially available (CryoProbe, Bruker Biospin AG, Fällanden, Switzerland). 
Physiology and Anesthesia 
Additional challenges when imaging small animals, such as mice and rats, is the maintenance 
of stable physiology and the choice and control of anesthesia, as animals are commonly 
anesthetized.  
Stable physiology is of great importance as the detection of brain activation is based on a 
hemodynamic readout. In particular, the hemodynamic response is influenced by body 
temperature [37] and partial pressure of blood gases. Monitoring of body temperatures and 
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blood gas levels are therefore inevitable; blood gas levels also indicate how well ventilated the 
animal is. Endotracheal intubation and a well adjusted mechanical ventilation of the animal 
ensure stable arterial oxygen saturation and pCO2 levels, an important prerequisite for animal 
fMRI. Application of a neuromuscular blocking agent and stereotactic fixation of the head 
prevent artifacts in MR images related to movement of the object and therefore help 
reducing physiological noise.  
Anesthesia is a recurring issue in animal imaging, since any type of anesthesia will affect the 
neuronal or hemodynamic response to a stimulus. It is in the nature of anesthetics to render 
the animal unconscious and induce amnesia, muscle relaxation and analgesia [38]. It is 
therefore important to consider several points, before deciding on a particular anesthetic: 1) 
suitability for longitudinal studies; 2) receptor system(s) involved in anesthetic action; and 
influences on the 3) neuronal system, 4) neurovascular coupling, and 5) vascular system.  
One of the most frequently used anesthetic in fMRI is α-chloralose, as it fully preserves 
neurovascular coupling and does only act slightly analgesic [39]. However, it is severely 
harmful to rodents and therefore not suitable for longitudinal studies, which somehow 
counteracts the idea of non-invasive imaging. Another anesthetic, which allows full recovery 
of the animal and which is becoming increasingly popular in fMRI studies, is isoflurane. It is 
an inhalation anesthetic with some analgesic effects and some influence on the neurovascular 
coupling; however, if kept at low levels and well controlled, it allows to accomplish robust 
and reproducible fMRI studies [19-21, 40-48]. For a detailed review on animal anesthesia 
used for fMRI consult [49].     
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Pain comes from the Latin word poena, 
signifying penalty or punishment. It was 
probably the French philosopher and scientist 
René Descartes (1596-1650) who first 
described a concept of a pain pathway: “If for 
example fire comes near the foot, the minute 
particles of this fire (…) have the power to set in 
motion the spot of the skin (…) and by this means 
pulling upon the delicate thread which is attached 
to the spot on the skin, they open up at the same 
instance the pore against which the delicate thread ends, just as by pulling at the end of a rope one 
makes to strike at the same instant a bell, which hangs at the other end.” (R. Descartes, Traité de 
l’Homme, 1662). Today, pain is defined as “… an unpleasant sensory and emotional 
experience associated with actual or potential tissue damage …” by the IASP (International 
Association for the Study of Pain). Nociception, on the other hand, refers to signals arriving 
at the central nervous system (CNS), resulting from nociceptor activation, providing 
information about potential or real tissue damage.  
 
Pain does not equal pain; instead, several distinct types of pain exist. Nociceptive pain is an 
early-warning, physiological protective system, which is inevitable to detect damaging or 
noxious stimuli. This kind of pain is essential for survival and the lack of it is a serious 
problem. Rare genetic disorders leading to insensitivity to pain result in self-mutilation, 
amputations, joint deformities and early death [50, 51]. Inflammatory pain also serves to 
protect the body by increasing the sensitivity after tissue damage. Hypersensitivity protects 
the injured site by reducing the risk of further damage by preventing contact with, or 
movement of the injury. The third type of pain is not protective but maladaptive and is due 
to an abnormal function of the nervous system. Pathological pain can occur after lesions of 
 
Figure 1-3: Illustration of the pain pathway 
in René Descartes' Traite de l'homme, 1662.  
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the nervous system (neuropathic pain), but also appears in patients without neural damage 
(dysfunctional pain). The underlying mechanisms of pathological pain are still not fully 
understood, but are most likely due to amplified sensory signaling in the CNS [52, 53]. 
Functional imaging may provide a tool to gain further insight to these mechanisms, as it 
already revealed structural changes in the brain associated with chronic pain [54].  
 
Figure 1-4: Primary sensory afferents transmit information from the peripheral tissues to the spinal 
cord. Their cell bodies are located in dorsal root ganglia (DRG). Large diameter, myelinated Aβ-fibers 
are involved in non-noxious sensation, transmitting information via the dorsal column pathway. The 
nociceptors, small diameter unmyelinated C-fibers or thinly myelinated Aδ-fibers, detect noxious 
stimuli, which are relayed to the brain via the spinothalamic tract.   
 
The perception of nociceptive pain starts at specialized, primary afferent high-threshold 
neurons with free nerve endings, the nociceptors. Noxious information is transmitted by two 
types of small-diameter neurons, the thinly myelinated Aδ-fibers and to a greater part by the 
unmyelinated C-fibers. However, not all C- and Aδ-fibers are nociceptors, as some of them 
also transmit signals from innocuous mechanical, warm and cold stimuli. The cell bodies of 
all primary afferents are located in the dorsal root ganglion (DRG), from where one axon 
innervates peripheral tissue and reacts to peripheral stimuli, whereas another axon projects to 
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the dorsal horn of the spinal cord to relay information to the CNS. The basic function of 
nociceptors is to transmit information about damaging stimuli to higher-order neurons in the 
spinal cord. Many subclasses of nociceptors have been described, responding to cold, warm, 
noxious heat, mechanical stimulation or being multimodal [55-58].  
Many receptors and ion channels responding to specific sensory stimuli have been identified 
in the past 30 years. Particularly the transient receptor potential (TRP) channel family plays 
an important role in nociception, particularly in the detection of heat and cold stimuli (for 
reviews: [59, 60]). The most prominent member of the TRP family is the polymodal 
vanilloid receptor 1 (TRPV1, VR1), also known as the capsaicin receptor. TRPV1 receptors 
are directly activated by capsaicin, the pungent ingredient of chili peppers, noxious heat, 
spider toxins and can be modulated by low pH [61, 62]. They are mainly associated with a 
subgroup of C-fibers that respond to noxious heat [63]. Besides TRPV1, there are numerous 
other receptors and ion channels involved in the perception of sensory stimuli; a summation 
of all inputs from the different types of primary sensory afferents generates the pain 
sensation.  
Pain perception, however, is not an absolute value, but can be enhanced or diminished by 
many factors, such as attention, expectations, emotional state, anxiety, or associated past 
experiences and memories [64]. Neuroimaging techniques have revealed a so called ‘pain 
matrix’ of brain areas which are consistently, but not exclusively, activated upon noxious 
stimulation. These areas include the primary and secondary somatosensory cortices (S1, S2), 
anterior cingulated cortex (ACC), insular cortex (IC), prefrontal cortex (PFC), thalamus, 
periaqueductal gray (PAG), basal ganglia, cerebellum and the amygdala [65, 66], and these 
data acquired with functional imaging are consistent with anatomical studies [67, 68].  
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Figure 1-5: Schematic representation of the human brain, illustrating the ascending pain pathways 
and regions involved in pain processing (‘pain matrix’). S1: primary somatosensory cortex; S2: 
secondary somatosensory cortex; M1: primary motor cortex; ACC: anterior cingulated cortex; PCC: 
posterior cingulated cortex; SMA: supplementary motor area; BG: basal ganglia; PFC: prefrontal 
cortex; HT: hypothalamus; PB: parabrachial nuclei; PAG: periaqueductal gray; PPC: posterior 
parietal cortex. Adapted from [67]. 
 
The pain matrix contains brain areas not only involved in nociception, but also in emotion 
and cognition, and they overlap with brain sites activated by placebo effects or opioids [69]. 
The perception of pain is mediated by interaction of all these regions, and modulated by a 
descending modulatory circuit, which receives input from different areas. The opioid-
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sensitive descending modulation contributes to pain relief, as observed with the placebo 
effect, but has the ability to facilitate pain as well. Many centrally acting pain-relieving drugs 
activate or mimic the descending modulatory pathways, in order to diminish the pain 
experience (for review: [64]).   
Many of these insights have been gained through neuroimaging studies which are becoming 
increasingly important in pain research (for review on neuroimaging of pain: [54]). 
Establishment of robust fMRI protocols to assess nociception in animals will allow getting 
further insight to different aspects of normal and pathological pain states; and is particularly 
interesting with regard to the many transgenic mouse models available.  
Currently, rats are still the dominating species used for fMRI pain research, but with the 
availability of higher magnetic fields, mice are becoming increasingly popular. Nevertheless, 
only a few mouse studies have been published so far, most of them focusing on the methods 
used, and only to a lesser extent on biological applications and mechanisms [46, 70-72]. Rat 
fMRI, on the other hand has been used extensively to analyze many different aspects related 
to pain processing, including hyperalgesia [73], noxious and/or innocuous stimulation [25, 
74-80], effects of stroke [21, 24], effects of different anesthetics [44, 81-84], nociceptive 
processing in the spinal cord [85-87], and functional connectivity and reorganization [47, 88, 
89]. The application of these techniques to mice would be very promising in order to test 
different transgenic models of pathological pain.         
1.5 Aim of the Thesis 
The goals of the current work were the establishment and application of robust BOLD fMRI 
paradigms for mice. This comprised: 1) Developing and implementing robust BOLD fMRI 
protocols to assess brain responses to somatosensory and noxious stimulation. 2) Application 
of these protocols to different transgenic mouse models or to wild type mice subjected to 
pharmacological treatment.  
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Functional imaging has become an important tool in pain research to better understand the 
mechanisms underlying pathological pain. Non-invasive BOLD fMRI to measure 
nociception in rats has been well established in different labs [47, 48, 90, 91]. However, 
robust BOLD fMRI studies in mice are still sparse, but of great interest in view of the many 
transgenic mouse lines available. 
Therefore, the first part of this thesis was dedicated to establish an electrical forepaw 
stimulation paradigm for mice at a 9.4 T scanner using the CryoProbe. This allowed for 
sufficiently high SNR, temporal and spatial resolution, to monitor BOLD signal changes of a 
few percent in small brain areas. An important aspect, beside the challenges of setting up a 
suitable fMRI protocol, was the tight control and maintenance of stable physiology of the 
mouse. This is critical for consistent BOLD signal readouts, since the technique relies on a 
well functioning hemodynamic system.  
Two stimulation paradigms were developed to address questions related to somatosensory 
and nociceptive processing in mice. Repetitive stimulations of one paw, corresponding to a 
block design of stimulation and resting phases, were implemented to allow for statistical 
analyses based on voxel-by-voxel correlation. Prerequisites for the development of an 
applicable stimulation paradigm were robustness of the signal, high reproducibility, low 
inter-individual variability and a BOLD signal change which scaled with stimulus strength.  
Electrical stimulation was performed at different amplitudes, ranging from innocuous to 
noxious, in order to obtain a ‘dose-dependent’ response. Once the paradigm was well 
established, we compared the performance of the 400 MHz CryoProbe to a room 
temperature (RT) coil of similar dimensions. This comparison has been performed earlier by 
evaluating phantom and anatomical data [36], while in this study we investigated the gain of 
sensitivity relevant for fMRI applications. In addition, we analyzed the effect of different 
temperatures of the ceramic shield of the coil, which is in direct contact with the mouse 
head, and its effect on BOLD signals and CBV. 
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The second part of this work was focused on application of the electrical stimulation 
paradigm to pharmacologically treated wild type mice and to different transgenic mice.  
In order to establish a different stimulation paradigm, the last part of the thesis was dedicated 
to the development and implementation of a heat stimulation paradigm, using infrared laser 
diodes. Heat is a physiological stimulus which directly activates specific thermoreceptors on 
the primary afferents. It may therefore be more meaningful for certain applications than the 
electrical stimulation. The heat paradigm, with a temperature-controlling feedback-loop, was 
tested for two different temperatures. The specificity of the paradigm was tested using 
pharmacological interventions. 
 Published article: ’’Assessment of Brain Responses to Innocuous and Noxious Electrical Forepaw 
Stimulation in Mice Using BOLD fMRI’’; Simone C. Bosshard, Christof Baltes, Matthias T. Wyss, 
Thomas Mueggler, Bruno Weber, Markus Rudin; PAIN, 151 (2010) 655–663. 
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2. Assessment of Brain Responses to 
Innocuous and Noxious Electrical Forepaw 
Stimulation in Mice Using BOLD fMRI 
2.1 Introduction 
Processing of noxious stimuli involves different levels and structures of the neural system. In 
spite of substantial progress in understanding the molecular mechanisms underlying pain, 
many aspects are still poorly understood. Genetically engineered mouse lines displaying 
altered or pathological pain states may help to elucidate the physiological and molecular basis 
of normal and pathological pain processing [92-95]. Classically, sensory responsiveness in 
animals is characterized using behavior tests such as the hot plate, von Frey filaments or tail 
flick test [96]. These analyses, however, depend on the skills of the experimenter and require 
undisturbed motor function of the animal. Electrophysiological recordings of neuronal 
activity provide high spatial and temporal resolution. However, the method is invasive and 
does not allow recording signals over extended brain areas in a limited time period. An 
objective readout of neuronal signal processing that is non-invasive, independent of the 
observer performance and capable of covering the entire brain would be highly desirable. 
Functional magnetic resonance imaging (fMRI) has been widely used to assess changes in 
brain activity evoked by noxious stimuli. Noxious-evoked activation patterns revealed by 
fMRI correspond well with the structures of the pain processing pathway both in humans 
and animals [97-101]. There are two peripheral nerve types which process sensory input: low 
threshold fibers, mainly Aβ, primarily mediate touch, while high threshold fibers, mainly Aδ 
and C, conduct nociceptive signals [75]. The response to peripheral sensory or noxious 
stimulation in rats has been studied in depth [48, 90, 91]. In contrast, only few fMRI studies 
in mice using electrical stimulation paradigms have been reported to date [70-72, 102]. This 
is mainly due to experimental challenges related with the small size of mice, putting high 
demands on spatial resolution and thus sensitivity. Another challenge for robust fMRI 
 31 2.2 Materials and Methods 
measurements in mice is the maintenance of stable physiological conditions. While human 
fMRI experiments are carried out in awake subjects, the large majority of animal fMRI 
studies are performed in anesthetized animals. Therefore, anesthesia should neither interfere 
with brain activity nor act analgesic when investigating the response to noxious stimulation 
paradigms. Unfortunately, there is no such ideal anesthetic suitable for longitudinal studies 
e.g. for studying functional changes over time. In this work we used isoflurane, the 
advantages of which are ease of administration and controlled dosing. Despite these 
challenges, the development of robust mouse fMRI protocols is highly desirable for 
investigating mechanistic aspects of signal processing under normal and pathological 
conditions. 
The aim of this study was to develop a reliable stimulation paradigm to analyze the 
somatosensory and nociceptive system in mice under isoflurane anesthesia. The high 
sensitivity of a cryogenic surface coil enabled detailed analysis of the BOLD response in 
activated brain regions elicited by electrical stimulation of the mouse forepaw as a function of 
time. BOLD signal intensities were found to correlate well with the amplitudes of the 
electrical stimulation applied. The quantitatively assessed dynamics of the temporal profile of 
the BOLD response yielded further insight into the hemodynamic response to electrical 
stimulation.  
2.2 Materials and Methods 
Animal Preparation  
All experiments were performed in accordance with the Swiss law of animal protection. 15 
female C57Bl/6 mice weighing 22 ± 3 g were anesthetized with Isoflurane (induction 2-3 %, 
maintenance 1.2 % in a 70 % air – 30 % oxygen mixture; Abbott, Cham, Switzerland), 
endotracheally intubated and mechanically ventilated throughout the entire experiment to 
ensure stable physiology (90 breaths/minute, respiration cycle: 25 % inhalation, 75 % 
exhalation; Maraltec, Alfos Electronics, Biel-Benken, Switzerland). Animals were paralyzed 
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by intravenous (i.v.) administration of a neuromuscular blocking agent (Pancuronium 
bromide, 1.0 – 1.5 mg/kg; Sigma-Aldrich, Steinheim, Germany), which avoided interference 
by spontaneous breathing and prevented movement artifacts during the fMRI experiments 
despite the low isoflurane levels. A rectal temperature probe (MLT415, AD Instruments, 
Spechbach, Germany) was inserted to keep the animal at 36.5 ± 0.5 °C. Body temperature 
was maintained using a warm-water circuit integrated into the animal support (Bruker 
BioSpin AG, Fällanden, Switzerland). A transcutaneous electrode (TCM4, Radiometer, 
Copenhagen, Denmark) was placed on the shaved upper hind limb of the mouse to measure 
blood gas levels (pCO2). In some animals, heart rate and blood oxygenation were monitored 
using a MR-compatible infrared sensor (MouseOx® Pulse Oximeter, Starr Life Sciences, 
Oakmont, PA, USA). For accurate and reproducible positioning, the head of the animals was 
fixed with stereotactic ear bars and eye cream was applied to prevent the eyes from becoming 
dry. For the electrical stimulation a pair of needle electrodes (Genuine Grass instruments, 
West Warwick, USA) was inserted subcutaneously into the distal and proximal end of the 
palm of each forepaw with a distance of 2-3 mm between the two needles (Fig. 2-1). The 
identical set-up and parameters (1.5 mA) were used to stimulate the hind paw of four 
animals.  
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The entire experiment lasted approximately 2 hours, of which 20 min were used for 
preparation of the mouse, and the remaining time was used for acquiring fMRI data. The 
mice were anesthetized throughout the duration of the experiment. Animals were used for 
more than one experiment.  
MRI Equipment and Sequences 
All MRI experiments were performed on a Bruker BioSpec 94/30 small animal MR system 
(Bruker BioSpin MRI, Ettlingen, Germany) operating at 400 MHz (9.4 Tesla). For signal 
transmission and reception a commercially available cryogenic quadrature RF surface probe 
(CryoProbe), consisting of a cylinder segment (180° coverage, radius = 10 mm) and 
operating at a temperature of 30 K was used (Bruker BioSpin AG, Fällanden, Switzerland) 
(for detailed information see [36]). The ceramic outer surface of the coil touching the mouse 
head was kept at 30 °C using a temperature-controlled heating device.  
Anatomical reference images in coronal and sagittal directions (slice orientations are given 
using the nomenclature of the mouse brain atlas [103]) were acquired using a spin echo 
(Turbo-RARE) sequence with the following parameters: field-of-view (FOV) = 20 x 20 mm2, 
matrix dimension (MD) = 200 x 200, slice thickness (STH) = 0.5 mm, interslice distance 
(ISD) = 1.0 mm, repetition delay TR = 3500 ms, echo delay TE = 13 ms, effective echo time 
TE,eff = 39 ms, RARE factor (number of echoes sampled for each excitation) = 32, and 
number of averages (NA) = 1. Subsequently, the slices for the fMRI experiment were planned 
on the anatomical reference image and BOLD fMRI data were acquired using a gradient-
echo echo-planar imaging (GE-EPI) sequence with the following parameters: Five coronal 
slices covering a range of 2 to 5 mm anterior to the interaural line were recorded with FOV = 
23.7 x 12.0 mm2, MD = 90 x 60 (acquisition) and 128 x 64 (reconstruction) yielding an in-
plane resolution of 200 x 200 μm2, STH = 0.5 mm, ISD = 0.7 mm, TR = 2500 ms, TE = 8.5 
ms, and NA = 3 resulting in an image acquisition time of 7.5 seconds. The individual 
sections comprised the forelimb and hind limb areas of the somatosensory and insular 
cortices, and the thalamus [103]. An fMRI experiment consisted of 112 repetitions and 
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lasted 14 min, except for the group of 2.0 mA, where the acquisition consisted of 96 
repetitions and lasted 12 min.  
Electrical Stimulation Paradigm 
Electrical pulses of 0.5 ms duration at a frequency of 3 Hz were applied. Current amplitudes 
were 0.5 mA (n = 8 animals), 1.0 mA (n = 8), 1.5 mA (n = 7), and 2.0 mA (n = 8) [104]. 
The stimulus strength is determined by the local current density (electric current per unit 
area of cross section), which itself depends on the placement of the electrodes. Current 
thresholds for noxious stimulation were estimated from an experiment on the hairy skin of 
the wrist of a volunteer with analogous electrode placement as in mice (distance between 
electrodes). Stimulation amplitudes of 1.5 and 2.0 mA were experienced as being painful, 
while the amplitude of 0.5 mA was clearly innocuous. Although innervation of human and 
mouse skin may differ, a noxious threshold in the range of stimulation amplitude of 1.0 mA 
appears reasonable.  
The stimulation paradigm consisted of a block design starting with a resting period of 120 
seconds (baseline) followed by 60 seconds of stimulation. This series was repeated four times 
and fMRI data recording was continued for another 120 seconds after the last stimulation 
block. The duration between positioning of the mouse in the magnet bore and the beginning 
of the electrical stimulation and fMRI recording was kept constant at 40 minutes to ensure 
the same anesthesia conditions for all animals. This time was used for adjustment of MRI 
conditions as well as anatomical reference and high resolution scans. Stimulation started with 
the left paw in all animals. Following an 8 minute resting interval, the right paw was 
stimulated. These two stimulation cycles were followed by a control acquisition without 
electrical stimulation. 
Data Analysis 
Four regions of the brain were evaluated in detail, including the somatosensory cortex S1 
contralateral and ipsilateral to the stimulated paw, the thalamus and a control region at the 
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ventral pallidum, a structure involved in neither the sensory nor the nociceptive pathway. In 
addition, we looked at the S2, insular and piriform cortex in the 1.5 mA group. Statistical t-
maps were calculated using the general linear model (GLM) tool integrated in the Biomap 
software program (M. Rausch, Novartis, Switzerland). GLM assesses correlations on a pixel-
by-pixel basis between the fMRI signal train and the stimulation paradigm. Activation was 
detected using a statistical threshold of p = 0.0001 for all experiments. With a minimal 
cluster size of 15 voxels, two coronal sections were analyzed, of which one slice covered the 
thalamus, the secondary somatosensory (S2) and insular cortex (IC) (2.8 mm anterior to the 
interaural line (IAL +2.8 mm)) and the other covered the forepaw areas of the primary 
somatosensory cortex (S1) (IAL +3.7 mm). The respective regions-of-interests (ROIs) derived 
from the GLM analysis, were used to extract BOLD signal changes as a function of time. In 
cases for which the correlation analysis revealed no activated voxels at the expected locations 
as well as for the unstimulated scans ROIs were transferred from the mouse brain atlas [103]. 
For group analysis, EPI images covering the S1 area (IAL +3.7 mm) and the thalamus (IAL 
+2.8 mm) were normalized to the coordinate system of the mouse brain atlas [103]. The 
fMRI coordinates were defined as followed: the origin of the right-hand coordinate system 
was chosen at the ventral end of the brain midline through the coronal sections. The second 
reference point was the dorsal end of the same midline, while the third point was placed on 
the edge of the right hemisphere at its widest point. The coordinate axes were defined along 
the midline (y-axis) and perpendicular to it (x-axis). The axes were then scaled to fit the 
dimensions of the mouse brain atlas, using an IDL-based software developed in-house [47]. 
For a detailed analysis of the fMRI time curve, the resulting BOLD profile was segregated 
into two components S (‘slow’) and F (‘fast’). Component S was extracted by fitting the 8 
data points before stimulation onset (light gray bars, shown in Fig. 2-4a, b) to a gamma-
variate function: 𝑦(𝑡) = 𝑎 ∙ 𝑡𝑟 ∙ 𝑒𝑥𝑝(−𝑘 ∙ 𝑡) with a (amplitude factor), r (power of growth 
curve), k (rate of exponential decay) being the parameters to be optimized, while t is 
measured with regard to the start of the first stimulation period (t = 0). The best fit curve 
(solid line, Fig. 2-3b) was then subtracted from the original data to yield component F of the 
fMRI signal (Fig. 2-4c). The maximal amplitudes of the fitted curve for component S and of 
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the extracted curve for the first stimulation period of component F (see Fig. 2-4) were 
analyzed as a function of the stimulation amplitude. The quantitative analysis was carried out 
for all ROIs.  
We furthermore analyzed the rates of BOLD signal increase and decay for both the first 
stimulation cycle and the entire stimulation period. The data points of the signal decay at the 
end of the stimulation interval (indicated by the dotted line in Fig. 2-6a) were used to 
calculate a decay constant koff assuming a single exponential decay function, 𝑆(𝑡) =
𝑆(𝑡 = 0) ∙ 𝑒𝑥𝑝�−𝑘𝑜𝑓𝑓 ∙ 𝑡�, with S(t) indicating the signal amplitude during the decay at 
time t and 𝑆(𝑡 = 0) the amplitude at the end of the stimulation period (t = 0). A minimum 
of four data points of the decay curve with an amplitude exceeding noise levels were required 
for each individual signal curve to allow for fitting. The BOLD signal decay rate constant was 
then correlated to the maximum BOLD response Smax of the single animals (Fig. 2-6c).  
The constant kon describing the initial build-up of the signal at the beginning of the 
stimulation to its maximum was calculated assuming the following relation: (𝑡) = 𝑆𝑚𝑎𝑥 ∙[1 − 𝑒𝑥𝑝(−𝑘𝑜𝑛 ∙ 𝑡 𝑆𝑚𝑎𝑥⁄ )] for which the initial slope yields (𝑑𝑆(𝑡) 𝑑𝑡⁄ )𝑡=0 =  𝑘𝑜𝑛, i.e. the 
initial slope was assumed to be independent of the maximum BOLD signal. 
Autoradiography and Intrinsic Optical Imaging 
Autoradiography with [18F]-2-fluoro-2-deoxyglucose (18F-FDG) was performed on two 
female C57Bl/6 mice according to published protocols [105, 106]. The left forepaw was 
electrically stimulated at 1.5 mA using the parameters described above. A 5 minute 
stimulation period was followed by a one minute break. This was repeated for the entire time 
course of 45 minutes, before the animals were sacrificed and the brain extracted.    
One mouse was used for intrinsic optical imaging. Reflectance from 570 nm light was 
measured through the exposed skull using a CCD camera. The left forepaw was stimulated 
with a 10 second pulse train of 0.5 ms pulses of 1.0 mA current amplitude at 3 Hz. These 
experiments were carried out under 1.5 % isoflurane anesthesia.  
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2. 3 Results 
Animal Physiology and Anesthesia 
Non-invasive monitoring of the mice showed stable physiology throughout the duration of 
the experiments. Blood gas levels of pCO2 measured transcutaneously were in the range of 40 
± 10 mm Hg, which indicates a well adjusted ventilation of the animals [107]. Body 
temperature was kept stable at 36.5 ± 0.5 °C for the entire experiment. The monitored heart 
rate was stable around 500 beats per minute in all animals and no changes were detected 
during the stimulation. After completion of the fMRI investigation, the animals recovered 
fast and could be used for further experiments, an important prerequisite for longitudinal 
studies.  
Signal and Image Quality 
By exploiting the significant gain in sensitivity provided by the use of a cryogenic RF surface 
coil for signal detection [35, 36], BOLD fMRI data sets of high quality suitable for 
reproducible quantitative analysis have been obtained. Comparing the CryoProbe with a 
conventional room temperature coil of similar dimensions (for detailed information on the 
coils see [36]) using the GE-EPI sequence, a gain in image signal-to-noise ratio (SNR) of a 
factor of 3.1 ± 0.7 (mean ± standard deviation, unpublished data) was achieved. Using a 
coronal slice orientation proved advantageous as cross-sectional images recorded ≥ 3 mm 
anterior to the interaural line were largely devoid of geometrical distortions caused by local 
magnetic field inhomogeneities due to different magnetic susceptibilities of adjacent tissue 
compartments. In caudal brain structures, significant susceptibility artifacts have been 
observed due to the proximity of the air filled ear cavities. This also impaired the quality of 
images recorded in horizontal plane view, which would allow covering larger brain areas. 
Distortions caused by differences in susceptibility are experienced on an absolute scale, i.e. 
they affect more extended brain regions in mice than in rats due to the smaller dimensions of 
the mouse.  
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fMRI data showed good reproducibility (e.g. see error bars in Fig. 2-2g, h) and allowed for 
assessing differences in the BOLD response during stimulation at different amplitudes.  
Spatial Distribution and Intensity of the BOLD Response 
The spatial distribution of the activated areas after forepaw stimulation at 1.5 mA (threshold 
p=0.0001, cluster size: 15 voxels) for one representative animal is shown in Figure 2-2. The 
position of five coronal slices is indicated in the sagittal section shown in Figure 2-2a. Besides 
the forepaw S1 region activated areas are present in other S1 areas (Fig. 2-2c-f), the primary 
motor cortex (Fig. 2-2c-f), and several nuclei of the thalamus, including the ventral posterior 
nucleus which relays somatosensory information to the cortex (Fig. 2-2f) [103]. Figure 2-2i 
shows the distinction of the forepaw area (blue) and the hind paw area (red) after the 
respective stimulation as an activation map of two representative animals. As expected, hind 
paw somatosensory S1 areas were located median to the respective forepaw regions. The 
activated cluster at the brain midline reflects signal contributions from the sagittal sinus. No 
consistent deactivations were detected in any region of the brain.  
Figure 2-3 shows statistical maps (threshold p=0.0001, cluster size: 15 voxels) depicted on 
the mouse brain atlas ([103], Fig. 2-3a-f: IAL +3.7 mm, Fig. 2-3g-l: IAL +2.8 mm) obtained 
from all animals at different stimulation amplitudes ((a, g) 0.5 mA, (b, h) 1.0 mA, (c, i) 1.5 
mA, (d, j) 2.0 mA). The activated clusters of individual animals were overlaid, i.e. the 
intensity in the activation map corresponds to the number of animals displaying a significant 
BOLD signal (left and right forepaw for each animal). Activation in response to the forepaw 
stimulation appears in the somatosensory S1 and S2 cortices, in the thalamus and at higher 
amplitudes in the insular cortex (regions indicated in Fig. 2-3e, k). For all activated regions, 
the spatial extent of BOLD response exceeded the topological area defined on the basis of the 
mouse brain atlas [103]. This is attributed to the fact that fMRI assesses the hemodynamic 
response elicited by neural activity and not the neural activity per se. 
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Figure 2-2: Spatial distribution of the 
BOLD activation. (a) Sagittal reference 
image indicating the positions of the 
coronal EPI slices covering a large section 
of the mouse forebrain. (b)–(f) Spatial 
distribution of the activated clusters (p = 
0.0001) of one representative animal 
after unilateral forepaw stimulation. The 
left side of the image corresponds to the 
left hemisphere. Nominal distance to the 
interaural line (IAL) is given for each 
slice. Scale bar indicates 5 mm. Activated 
areas include the S1 forelimb area (c, d, 
e); motor cortex M1 (c, d, e); and several 
nuclei of the thalamus, including the 
ventral posterior nucleus which relays 
somatosensory information (f). Activated 
clusters are also observed at the sagittal 
sinus (e, f). (g) Time course of the 
BOLD signal after unilateral electrical 
stimulation of the forepaw at 1.5 mA for 
S1 contralateral to the stimulated paw 
(pink), S1 ipsilateral (dashed black), 
thalamus (gray), and the control region 
(light gray). Gray bars indicate the 
stimulation periods. The BOLD signals 
of the contralateral and ipsilateral S1 are 
almost identical. (h) Maximal signal 
amplitude of different regions (S1, S2, 
insular cortex (IC), piriform cortex (PC, 
control region)) ipsi- (black circles) and 
contralateral (pink squares) to the 
stimulated paw at 1.5 mA. All values are 
given as mean + SEM. (i) Activation map 
of two representative animals showing 
activation of the forepaw (blue) and hind 
paw (red) S1 area after stimulation of the 
respective paw at 1.5 mA, overlaid on an 
EPI image. Scale bars indicate t-values.    
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BOLD Signal Changes in Correlation to the Forepaw Stimulation Paradigm  
The maximal BOLD signal intensity increased with increasing stimulation amplitude in all 
analyzed regions involved in sensory and nociceptive processing in a comparable manner as 
in the regions shown in Figures 2-4 and 2-5. Stimulation at the lowest amplitude of 0.5 mA 
led to a maximal BOLD signal of 0.93 ± 0.25 % (in % of baseline intensity) in the primary 
somatosensory cortex contralateral to the stimulated paw. For amplitudes of 1.0, 1.5, 2.0 
mA, the maximal BOLD signal changes in this region amounted to 1.94 ± 0.20 %, 2.54 ± 
0.22 %, and 3.52 ± 0.41 %, respectively (Fig. 2-4a). The maximum BOLD amplitude 
decreased for subsequent stimulation periods. Interestingly, the signal did not return to the 
initial baseline level within the two minutes resting interval following a stimulation episode, 
but stayed elevated until the start of the next stimulation block. The BOLD response to 
unilateral forepaw stimulation appeared consistently bilateral in all activated regions, 
including the S1 (Figs. 2-2, 2-3), thalamus, S2 and insular cortex (for 1.5 mA: Fig. 2-2h). 
The maximal BOLD signal amplitude in the regions of the S2 somatosensory and insular 
cortex was significantly lower as compared to the S1 area. This was observed at all 
stimulation amplitudes except at 0.5 mA, where the amplitudes for S1 and S2 area reached 
similar values (data not shown). There was no delay between ipsi- and contralateral responses 
within the time scale of the fMRI experiment (7.5 s temporal resolution). 
The control region, which was located in the ventral pallidum, a structure not involved in 
sensory or nociceptive processing, showed no change in BOLD intensity for stimulation 
amplitudes ≤ 1.5 mA (Fig. 2-2g, 1.5 mA). At 2.0 mA a maximum signal increase of 0.81 ± 
0.12 % was detected. This unspecific increase in the BOLD signal was observed in large parts 
of the brain. A second cortical control region, located in the piriform cortex, behaved 
comparable to the ventral pallidum (for 1.5 mA: Fig. 2-2h). No region-specific activation 
whatsoever, but only background noise was revealed by the analysis of the control fMRI data 
sets acquired without stimulation, indicating the stability of the fMRI set-up including the 
physiological preparation (data not shown).  
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Figure 2-3: Activation maps of the cortex after left and right forepaw stimulation at (a, g) 0.5 mA, (b, 
h) 1.0 mA, (c, i) 1.5 mA, (d, j) 2.0 mA. Data show activated clusters derived from GLM analysis (p = 
0.0001, cluster size: 15 voxels) for all animals overlaid on the mouse brain atlas at IAL +3.7 mm (a-f) 
and IAL +2.8 mm (g-l) [103]. (e-k) Mouse brain atlas with relevant regions (SI: primary 
somatosensory cortex, forepaw region; SII: secondary somatosensory cortex; IC: insular cortex; MI: 
primary motor cortex; TN: thalamic nuclei) overlaid on the anatomical image. (f, l) Representative 
EPI image revealing relatively little distortions. (g-j) Activation maps; intensity indicates the number 
of stimulation periods displaying significant BOLD activation at a given location (scale bar). 
 
Amplitudes of the Two Signal Components S and F as a Function of the Stimulation 
Amplitude  
The temporal profile of the BOLD response has been segregated into the two signal 
components S and F by fitting component S to a gamma-variate function and subtracting the 
best fit from the experimental data (Fig. 2-4b, c). Analysis of the maximal amplitude of both 
components for the two S1 regions and the thalamus was found to correlate with the 
stimulation amplitude. Linear regression analysis yielded correlation factors for component S 
(Fig. 2-6a) of R2 = 0.98 for the contralateral, R2 = 0.97 for the ipsilateral somatosensory 
cortex and R2 = 0.81 for the thalamus. The values for component F (Fig. 2-6b) were R2 = 
0.97 for contralateral S1, R2 = 0.98 for ipsilateral S1 and R2 = 0.87 for thalamus. 
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Figure 2-4: (a) Relative change of the BOLD signal intensity as a function of time during electrical 
forepaw stimulation for the different stimulation amplitudes. Dark grey bars indicate the stimulation 
periods, light gray boxes mark data points used for fitting the component S curve (b). (c) Signal 
component F obtained by subtracting (b) from (a). Values are given as mean + SEM. 
 
 
Figure 2-5: The amplitudes of the two components S (a) and F (b) as a function of the stimulation 
amplitude. (a) Linear regression analysis yielded correlation factors of R2 = 0.98 for the contralateral 
and R2 = 0.97 for the ipsilateral S1 somatosensory cortical area. The corresponding value for thalamus 
was R2 = 0.81. (b) For the fast component the correlation factors were: R2 = 0.97 for contralateral S1, 
R2 = 0.98 for ipsilateral S1 and R2 = 0.87 for thalamus. Values are given as mean ± SEM.  
Analysis of the Signal Dynamics of Component F 
Not only the amplitude but also the dynamic behavior of the BOLD response depended on 
the stimulation amplitude as demonstrated by the averaged temporal profile of component F 
of the first stimulation period of each animal (Fig. 2-6a). The maximum values for the S1 
region contralateral to the stimulated paw were: 1.19 ± 0.48 %, 1.69 ± 0.21 %, 2.47 ± 0.18 
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%, and 2.81 ± 0.37 % for 0.5, 1.0, 1.5, and 2.0 mA, respectively. A striking feature of the 
observed BOLD response (Fig. 2-4c, 2-6a, b) is that the signal amplitude started to decay 
despite ongoing stimulation. The signal maximum was observed typically 30 seconds after 
stimulation onset, thereafter the amplitude decreased significantly by 5 % to 15 %. The 
fitted curves (Fig. 2-6a) were computed assuming single exponential signal build-up and 
decay with parameters described in the Materials and Method section. The exponentially 
decaying vasodilatory response of the neuronal signal is characterized by a time constant kv = 
0.02 s-1.  
 
Figure 2-6: Analysis of component F of the fMRI 
response to electrical stimulation of the forepaw 
in the contralateral S1 cortical region. (a) Mean 
fMRI signal response for the first stimulation 
episode as a function of time and current 
amplitude. Solid lines indicate the BOLD 
response modeled as described in the text. The 
dashed line illustrates the vasodilatory stimulus, 
which displays a single exponential decay with a 
rate constant kv = 0.02 s-1. (b) The mean 
normalized fMRI response of the first stimulation 
period (normalized to 1) as a function of time 
and stimulation amplitude. The reduced rate of 
signal decay with increasing stimulus amplitude 
(and correspondingly higher maximum BOLD 
intensity) becomes apparent. For sake of clarity 
error bars have been omitted. (c) The decay rate 
constant of the BOLD signal of the single animals 
decrease with increasing maximal intensity of the 
BOLD signal. Linear regression yielded a 
correlation coefficient of R2 = 0.76. Values are 
given as mean ± SEM. 
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For the build-up of the BOLD signal the same initial rate kon = 0.002 s-1 was assumed, 
irrespective of the stimulation amplitude applied. In contrast, the value for the decay rate 
constant koff was found to decrease with increasing stimulation amplitude. This is also 
apparent when normalizing individual BOLD signals to the respective maximum intensity 
value (Fig 5b). Single exponential fitting for the averaged curves yielded first-order rate 
constants of koff values of 0.040 s-1 for 2.0 mA, 0.051 s-1 for 1.5 mA and 0.063 s-1 for 1.0 mA, 
displaying a linear dependence on the stimulation amplitude with a correlation factor of R2 = 
1.00 (data not shown). In the next step we tested whether the decay rate koff depended on the 
maximal BOLD change. We therefore used the average BOLD signals of all stimulation 
cycles (four stimulation blocks per stimulation amplitude), which fulfilled the criteria with at 
least four data points exceeding the noise level used for the fitting procedure (Fig. 2-4c): a 
significant negative correlation has been found with R2 = 0.76.  
Autoradiography and Intrinsic Optical Measurements 
The autoradiography data of the two animals (Fig. 2-7b) showed a clear bilateral increase in 
FDG uptake in the thalamus, consistent with the observed fMRI activation pattern (Fig. 2-
7a). Cortical activation was found to be weak. Bilateral local increases in cortical blood 
volume indicative of neuronal activation were detected using intrinsic optical imaging (Fig. 
2-7d), which is in line with our fMRI finding of bilateral cortical activation.     
  
45 2.4 Discussion 
 
Figure 2-7: Autoradiography and intrinsic optical imaging. (a) fMRI activation map of a 
representative animal. (b) 18F-FDG autoradiographies of two mice after unilateral forepaw stimulation 
show bilateral thalamic activation and some bilateral cortical activation (blue arrows). (c) Reflection of 
570 nm light used for intrinsic optical imaging reveals the vascular anatomy at both sides of the 
sagittal sinus. (d) Activation map of intrinsic optical imaging shows bilateral activation of the 
somatosensory area. Regions with increased cerebral blood volume are recognized by a decrease in 
signal intensity (blue). Color bar indicates changes in signal intensity in [%]. 
 
2.4 Discussion 
fMRI in rodents, predominantly in rats, has become an important tool in biomedical 
research e.g. to phenotype animal models of CNS disorders [19, 20, 40, 102].  In view of the 
many genetically engineered mouse lines the development of robust procedures for mouse 
fMRI protocols should be rewarding. By exploiting the significant gain in sensitivity 
provided by the use of a cryogenic RF surface coil for signal detection [35, 36], BOLD fMRI 
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data sets of high quality suitable for reproducible quantitative analyses have been obtained. 
The CryoProbe enabled fMRI at a spatial resolution of 200x200x500 μm3, which is 
sufficient to resolve the major cerebral structures of the mouse brain and allows for detailed 
anatomical and functional studies.  
The obtained fMRI data were highly reproducible with regard to both spatial extent and 
temporal profile. This allowed reliable detection of even small changes in the BOLD 
amplitude in response to stimulations at different current amplitudes. The BOLD intensity 
increased significantly at each stimulus onset, though there was a net decrease of BOLD 
amplitude for subsequent stimulation periods across the cycle consisting of four blocks. This 
was observed before [104, 108] and might be due to adaptation or habituation mechanisms, 
occurring either peripherally in the stimulated paw, or centrally in the brain. These 
mechanisms may also contribute to the signal decrease observed during ongoing stimulation 
(Fig. 2-4a, b).  
Due to the lack of clear evidence whether stimulation was noxious or not, the parameters 
used were tested on a human subject under the presumption that the threshold to activate C- 
or Aδ-fibers is similar in humans and mice. However, as the innervation pattern differs, the 
human values cannot be translated directly to the mouse but should rather be used as an 
estimate of the noxious threshold. This stands in contrast to a study by Nair and Duong, 
which reports hind paw stimulation with amplitudes up to 7 mA to be somatosensory only 
[71]. To our experience, the stimulation used in that study was likely to be noxious, at least 
at higher amplitudes.  
Data analysis revealed a robust activation of the S1 cortical forelimb area. However, the 
signal was not confined to the S1 region contralateral to the stimulated paw, but was also 
observed on the ipsilateral side with essentially the same amplitude and spatial extent. This 
stands in contrast to the majority of fMRI studies in healthy rats which report strictly 
unilateral responses during unilateral electrical stimulation [25, 77, 109, 110] including our 
own study using isoflurane anesthesia [47]. We performed additional experiments to 
modulate the laterality of the fMRI response: varying anesthesia depths, male instead of 
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female mice, or preparing only one paw with electrodes to prevent possible crosstalk between 
the leads carrying the needle electrodes. None of these interventions affected the bilateral 
symmetry of the activation pattern observed (data not shown). In addition, electrical forepaw 
stimulation at 1.5 mA in another strain (HsdWin:NMRI) showed the same bilateral 
activation pattern (data not shown). Bilateral activation of the areas responsible for pain 
processing has also been observed in humans [111-115]. These bilateral signals may be 
conveyed by fibers of the corpus callosum [116] or by commissural neurons of the spinal 
cord [117]. The occurrence of bilateral activation has also been reported previously for rat 
studies [118]. However, due to our relatively slow temporal resolution of 7.5 s, we were not 
able to resolve a possible delay between the onset of activation in the two hemispheres. Even 
increasing the temporal resolution to 1 s was not sufficient to reveal a potential delay of the 
ipsilateral versus the contralateral activation (data not shown).  
Although carried out with a small number of animals, autoradiography and intrinsic optical 
imaging experiments support our fMRI findings. Autoradiography revealed a distinct 
bilateral activation of the thalamus, most pronounced in the ventral posterior nuclei, 
structures known to relay nociceptive information. One mouse also showed bilateral cortical 
activation in the regions of S2, insula and motor cortex. The intrinsic optical measurement 
showed a clear bilateral activation of similar amplitudes in both hemispheres. These 
experiments, which were performed independently from our fMRI set-up, are in line with 
the results obtained with BOLD fMRI.     
Besides the S1 region, bilateral activation was observed in the thalamus, the motor, S2 and 
insular cortex. These regions are known to be part of the nociceptive network. Motor cortex 
activation might originate from antidromic stimulation of the efferent motor fibers as seen in 
a study by Cho and colleagues [76]. These activated areas are in accordance with those 
reported for similar studies in rats [109].  
Anesthesia is a recurring issue in animal imaging, in particular when investigating 
nociception. Isoflurane is an attractive anesthetic as it is easy to administer and control; 
however, there are also drawbacks. Isoflurane is a potent vasodilator causing a global increase 
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of cerebral blood flow (CBF) in a dose-dependent manner [119]. The basal energy level as 
derived from the cerebral metabolic rate of glucose consumption (CMRglc) is lower than in 
the awake state. A reduction by approximately 40 % was reported for an isoflurane 
concentration of 1.4 % [43]. In comparison, α-chloralose was found to reduce baseline 
CMRglc by approximately 60 % [118]. The higher energy consumption, the high CBF and 
concomitantly the dilated vessels in isoflurane anesthetized animals during baseline 
conditions reduce the dynamic range of the hemodynamic response as compared to α-
chloralose anesthesia [120, 121]. The vasodilatory effects however are dose dependent and 
can therefore be significantly reduced by using relatively low isoflurane levels (at around 1 
%). At this low level we assume reduced antinociceptive efficacy of isoflurane. Deady et al. 
showed that the hypnotic effects of isoflurane occurred at lower concentrations than the 
antinociceptive effects [122]. Also, low concentrations of isoflurane appear to exhibit 
minimal neuro-suppressive effects, as the flow-metabolism coupling was shown to remain 
preserved [123]. The robust BOLD response reported in this study as well as data from other 
studies performed under isoflurane anesthesia prove it to be a useful anesthetic for fMRI 
studies in rodents [19-21, 40, 45, 71]. 
A recent study [70] performed on mice using electrical forepaw stimulation claims the α2-
adrenergic receptor agonist medetomidine to be better for long time studies than other 
anesthetics. However, the occurrence of BOLD activation in less than 60 % of all scans 
performed (our study:  > 95 %) and the noisy temporal BOLD profiles do not clearly show 
the superiority of medetomidine anesthesia.  
When analyzing the temporal BOLD profile, it became obvious that it consists of two 
components, of which one is in phase with the stimulation (component F), while the other 
one is much slower, starting with the onset of the first stimulation (component S). The two 
components might be explained in terms of the underlying physiological processes: 
Component F being in phase with the stimulation episodes, is probably associated with the 
peripheral neuronal input of the A- and C-fibers, while the underlying signal described by 
component S might reflect a slow vascular response. 
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The BOLD signal amplitude of both components depended linearly on the stimulation 
amplitude. A similar linear dependence has been demonstrated using cerebral blood volume 
(CBV) [102] and CBF [104] measurements in mice and rats, respectively. Torebjörk et al. 
also showed that nociceptor responses and individual pain ratings in humans both linearly 
correlated with the applied heat stimulation [124].  
By averaging and normalizing the BOLD signal curves of all animals, it became apparent that 
the rate of the signal decay following a stimulation episode decreased with increasing 
stimulation amplitudes. Stimulation at high amplitudes led to a larger BOLD response and 
thus to a higher content of oxyhemoglobin (and correspondingly a lower concentration of 
deoxyhemoglobin) in the vessels, as compared to stimulations at lower amplitudes. This is in 
line with the hemodynamic model described by Friston and colleagues [125], which 
combines the balloon model with a linear dynamic model of changes in CBF as caused by 
neuronal activity. The balloon model describes the link between CBF and the BOLD signal 
and is able to predict nonlinear effects of the BOLD signal, which contrast the linear 
relationship of CBF and synaptic activity. The central concept of the model is to treat the 
venous compartment as an expandable balloon, which is inflated by an increase in CBF, 
leading to a dilution of the deoxygenated blood and an increased expelling rate of the blood 
[126]. The model predicts the recovery rate following a stimulation episode to be 
proportional to the amount of deoxyhemoglobin in the vessel [125-127], which is in line 
with our experimental results (Fig. 2-6). In contrast, the initial rate of the build-up of the 
BOLD response was found independent on the current amplitude within error limits. 
A further aspect that becomes apparent from the temporal profile of the BOLD response is 
that the BOLD amplitude decays during stimulation despite ongoing peripheral input. This 
can be explained by a decaying vasodilatory signal, which is also subject to feedback 
regulation by CBF, in response to a prolonged neuronal stimulus [77, 113]. The neuronal 
input is described as an initial peak followed by a decay to a lower level [125, 126]. 
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We could demonstrate that reproducible mouse BOLD fMRI data can be obtained following 
sensory stimulation. The high quality of the data and the use of isoflurane make longitudinal 
fMRI studies in mice feasible.  
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3. Increased BOLD Sensitivity in the Mouse 
Somatosensory Cortex during Electrical 
Forepaw Stimulation Using a Cryogenic RF 
Probe 
3.1 Introduction 
Functional MRI (fMRI) of small rodents puts high demands on the signal-to-noise (SNR) 
ratio of the MR acquisitions: i) changes in the BOLD (blood oxygen level dependent [26]) 
signal intensity during the resting state or in response to a stimulus do not exceed a few 
percent of the baseline signal intensity; ii) quantitative analysis of the BOLD time course 
requires a high temporal resolution as the hemodynamic response function is characterized by 
time constants of the order of seconds [128, 129]; and iii) the small dimensions of the rodent 
brain imply that high spatial resolutions (200-500 µm) are required in order to resolve 
functional brain structures. Substantial efforts have been made to improve the SNR for small 
animal MRI, e.g. to increase the signal by using higher main magnetic field strengths B0 [31]. 
However, with higher magnetic field strengths, the T2 and T2* relaxation times are inherently 
decreased, and T1 increases. Thus, MRI sequence parameters have to be adjusted (e.g. use of 
longer repetition delays, resulting in longer acquisition times) in order to extract maximum 
benefit from the increased polarization. Furthermore, the higher susceptibility differences at 
tissue interfaces (e.g. soft tissue-bone, soft tissue-air) intrinsically associated with higher 
magnetic fields will aggravate the severity of image artifacts. Alternatively, the signal can be 
improved by data averaging or by increasing the dimensions of the volume element (voxel) 
being sampled, which would compromise either temporal or spatial resolution. 
An attractive strategy to improve SNR is to decrease the noise level in the data.  In fMRI 
experiments three noise contributions must be considered: (i) the (thermal) noise of the 
receiver electronics, (ii) ‘static’ sample noise and, (iii) when analyzing serial MRI data 
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acquisitions, such as fMRI, noise originating from fluctuations in the physiological state of 
the animal caused, for example, by changes in metabolic rate, blood flow, blood volume, 
de/oxyhemoglobin concentrations, cardiac and respiratory motion. In humans, the effect of 
physiological noise on BOLD fMRI has been investigated in detail for various imaging 
parameters (spatial resolution, echo time, etc.) [32, 33] and for increasing field strengths (1.5, 
3, and 7 T) [34]. Recently, Kalthoff et al. [89] have investigated the effect of physiological 
noise on BOLD fMRI in the resting state in rats at 11.7 T. The first measure for the 
minimization of physiological noise in fMRI studies in small rodents is the stable preparation 
of the animal with respect to motion and hemodynamic conditions [48]. Stereotactic fixation 
or neuromuscular blocking agents are used to prevent motion artifacts. Furthermore, 
physiological parameters such as heart rate, blood gas levels and body temperature, must be 
monitored and maintained within physiological limits.  
For the small sampling volumes typical in rodent MRI the noise contributions of the 
biological sample and of the receiver electronics are of comparable order. Cooling of the 
radiofrequency (RF) coils and preamplifier has been shown to lead to an increase in SNR 
[130, 131]. In recent studies, SNR gains of a factor of 1.8 at 4.7 T [35] and a factor of 2.5 at 
9.4 T [36] have been reported for structural in vivo MRI of the mouse brain using cryogenic 
coils operating at 30 K. 
The aim of this work is to investigate to what extent physiological noise associated with 
BOLD fMRI studies affects the gains in SNR that have been reported for structural in vivo 
MRI when using detection at low temperature. For this purpose fMRI experiments in mice 
using an electrical forepaw stimulation paradigm were performed employing either a 400 
MHz cryogenic surface coil (dimensions: 27x20 mm2) operating in quadrature transceive 
mode, or a room temperature (RT) receive-only coil of comparable dimensions (28x17 
mm2). The fMRI data series was evaluated with respect to both the SNR within individual 
images and the temporal SNR (tSNR) between the images of the time series. The tSNR 
serves as quality measure for the analysis of an fMRI time series taking signal fluctuations 
between images into account, which originate from small temporal changes in the animal’s 
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physiology. Furthermore, as the cryogenic probe is equipped with a temperature-controlled 
thermal shield to insulate the mouse head from the cryogenic transceiver coil, the effect of 
the thermal shield temperature on the fMRI contrast-to-noise ratio (CNR) was evaluated. 
3.2 Materials and Methods 
Theory 
In MRI the SNR has been demonstrated to be linearly proportional to the main magnetic 
field strength B0 [132] and can be described as: 
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where γ is the gyromagnetic ratio, is Planck’s constant an k is Boltzmann’s 
constant. M0 is proportional to the main magnetic field strength B0 and inversely 
proportional to the absolute temperature T. In equation [1], ΔV represents the voxel 
dimensions, and NPE and NA are the number of phase encoding steps and the number of 
averages, respectively. Noise contributions σ are attributed to different sources: the thermal 
noise of the receiver chain σC and the sample noise σS (consisting of static noise of the subject 
σS,S, and physiological noise σS,P of the subject) [32, 33]. Assuming the noise contributions to 
be uncorrelated and of Gaussian type, we obtain  
𝜎 = �𝜎𝐶2 + 𝜎𝑆2                             [2] 
with       𝜎𝑆 = �𝜎𝑆,𝑆2 + 𝜎𝑆,𝑃2    . 
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Although, in structural human MRI, thermal noise of the receiver chain is negligible 
compared with the subject noise, σC and σS are of comparable order in small-animal MRI. 
Accordingly, reducing the noise contribution of the receiver chain by cooling RF coil and 
preamplifier results in an increased SNR. However, during serial MRI acquisitions, such as 
fMRI studies, the physiological noise σS,P constitutes a non-negligible contribution to the 
total noise, which depends on the signal levels. According to Krueger et al. [32, 33] the 
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where SNR0 is the single image SNR and λ represents a physical measure of the SNR 
degradation caused by physiological fluctuations over time. 
Typically, in BOLD fMRI studying the response to stimulatory input (e.g. sensory 
stimulation) two states are compared: the resting period and the activation period during 
stimulation. Accordingly, the (maximum) signal difference (ΔS) between the resting and 
activated state can be considered as a measure for the BOLD sensitivity (CNR) of the MR 






    .               [4] 
MR Instrumentation 
Imaging experiments were carried out on a preclinical small-animal MR system (BioSpec 
94/30, Bruker BioSpin MRI, Ettlingen, Germany) operating at 400 MHz and equipped with 
a gradient coil system capable of generating a maximum strength of 400 mT/m with a 
minimum rise time of 80 µs. Two RF coil set-ups were compared with respect to their 
sensitivity to detect BOLD signal changes in fMRI during sensory forepaw stimulation in 
mice. One coil set-up operating at RT (293 K) consisted of two coils driven in cross-coil 
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mode: a linearly polarized bird-cage resonator (inner diameter: 72 mm) for transmission and 
a curved rectangular quadrature receive-only surface coil [side-by-side overlapping coils; total 
size: 28 x 17 mm2 (arc length x length), outer dimension of one coil element: 20 x 17 mm2] 
(Bruker BioSpin MRI). The second coil set-up was a transceive cryogenic quadrature RF 
surface probe (CryoProbe, total size: 27 x 20 mm2; outer dimension of one coil element: 16 x 
20 mm2) operating at 30 K with an integrated cooled preamplifier (operating at 77 K). 
Although constant cooling of the CryoProbe was ensured using a closed-loop system 
connected to a remote cryocooler, the flexible design allowed for a fast and easy exchange of 
the cryogenic coil. The outer surface of the CryoProbe touching the animal’s head consisted 
of a cylinder segment (180° coverage; radius: 10 mm) and was equipped with a temperature 
sensor and a resistive heater controlled by a proportional, integrative and derivative (PID) 
unit. The temperature of the thermal shield could be freely adjusted over a wide range (20- 
38 °C) and was kept constant by the temperature-controlled heating system. This ensured a 
defined thermal environment for the animal and a complete thermal insulation from the cold 
RF coil. The distance between the cold RF coil to the outer surface of the coil assembly was 
about 1 mm. Both, the cryogenic RF probe and the appropriate cooling unit, were provided 
by Bruker BioSpin AG, Fällanden, Switzerland. 
Animal Preparation 
All in vivo experiments were carried out in strict adherence with the Swiss law for animal 
protection. Female C57Bl/6J mice were anesthetized using 1.5 % Isoflurane (Abbott, Cham, 
Switzerland) in an oxygen-air (20 % : 80 %) mixture. Animals were intubated using fine 
tubing made of polythene (inner/outer diameter: 0.4 / 0.8 mm; length: 25 mm) and 
artificially ventilated (Maraltec, Alfos Electronics, Biel-Benken, Switzerland) using the 
following settings: 90 breaths per min; inhalation / exhalation period: 25 % / 75 %.  
Furthermore, the neuromuscular blocking agent pancuronium bromide was administered at a 
dose of 1-1.5 mg/kg (Sigma-Aldrich, Steinheim, Germany) to paralyze the animals. Animals 
were placed in a prone position and ear bars secured reproducible positioning on the same 
animal support for both RT cross-coil and CryoProbe measurements. Physiological 
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parameters were monitored by a rectal temperature probe and a transcutaneous electrode 
(TCM4, Radiometer, Copenhagen, Denmark) on the upper part of the hind limb, 
measuring blood gas levels (pCO2). pCO2 levels remained stable throughout the experiment 
within physiological values of 35-50 mmHg, indicating a well adjusted ventilation [107]. 
The body temperature of the animals was kept at 36.0 ± 0.5 °C for all experiments, while the 
CryoProbe assembly temperature was varied between 20 °C and 38 °C. Five animals were 
measured in experiments investigating the accuracy of the fast B1 calibration method. In 
fMRI experiments 25 animals were examined in total: 16 using the CryoProbe (three at 20 
°C, three at 27 °C, seven at 30 °C, and three at 38 °C) and nine using the RT probe. 
Furthermore, the temperature on the scalp was measured in two animals as a function of the 
CryoProbe shield temperature (20, 27, 30, and 38 °C) and compared with that measured for 
the RT probe. Cerebral blood volume (CBV) measurements were performed in 13 animals: 
nine using the CryoProbe and four using the RT coil set-up. 
RF Pulse Angle Adjustment 
For surface coils, such as the CryoProbe, maps of the RF pulse angle distribution commonly 
are acquired to allow for an accurate pulse angle adjustment. However, conventional pulse 
angle mapping methods such as the double angle method (DAM) [133] are hampered by 
their long acquisition time, whereas, in contrast, short periods between the induction of 
anesthesia and actual fMRI acquisition are desired in fMRI experiments. For this reason, the 
Bruker standard adjustment method, using slice selective excitation (thickness: 1.5 mm) in 
coronal view, was chosen to allow for fast pulse angle adjustments within a few seconds. In 
the initial experiments this standard adjustment method was compared with DAM using the 
following acquisition parameters: field of view (FOV): 25.6x25.6 mm2; slice thickness 
(STH): 0.5 mm; acquisition matrix (MTX): 128x128; spatial resolution (RES): 200x200 
µm2; pulse angle α = 60° and 120°; echo time (TE)/effective echo time (TE,eff)/repetition time 
(TR): 30.0/30.0/7000 ms; number of averages (NA) = 1; scan time: 2x 14 min 56 s. 
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Functional MRI 
Anatomical reference images in axial and sagittal view were acquired using a rapid acquisition 
with relaxation enhancement sequence (RARE [134]) for positioning of the fMRI slices. The 
imaging parameters were as follows: FOV: 20x20 mm2; STH: 0.5 mm; MD: 200x200; RES: 
100x100 µm2; interslice distance (ISD): 1.0 mm, α = 90°; TE / TE,eff / TR: 13 / 39 / 3500 ms; 
RARE factor: 32; and NA = 1. Magnetic field homogeneity was improved prior to the fMRI 
acquisition by voxel-based shimming in the frontal cortex covering all fMRI slices using the 
FASTMAP technique [135]. BOLD fMRI experiments were performed using a gradient-
echo, echo-planar sequence (GE-EPI) with the following parameters: five slices of 0.5 mm 
thickness, FOV: 22.7x12.0 mm2; ISD: 0.7 mm; MD: 90x60 (acquisition) and 128x64 
(reconstruction); RES: 253x200 µm2; α = 90°; TE / TR: 8.6 / 2500 ms; NA = 3; temporal 
resolution: 7.5 s; 112 repetitions; total scan time: 14 min. The stimulation paradigm 
consisted of sequential bilateral forepaw stimulation with subcutaneous needle electrodes 
following a block design (amplitude: 1.5 mA, frequency: 3 Hz, pulse duration 0.5 ms). One 
stimulation cycle consisted of a 120-s ‘off’ period used as baseline and of four repetitions of 
60-s ‘on’ periods separated by 120-s ‘off’ periods. Consecutive stimulation cycles were 
separated by a resting period of 8 min. In addition, a GE-EPI acquisition with identical 
parameter settings was acquired without electrical stimulation. 
To investigate the effect of the CryoProbe thermal shield temperature on the BOLD 
sensitivity, fMRI protocols were repeated in different scan sessions adjusting for various 
thermal shield temperatures.  
As a measure of baseline perfusion the relative CBV (rCBV) was assessed using a spin-echo 
(RARE) sequence with the following parameters: five slices of 0.5mm thickness, FOV: 
23.7x12.0 mm2; ISD; 0.7 mm; MD: 90x56 (acquisition) and 128x60 (reconstruction); RES: 
264x214 µm2; α = 90°; TE / TE,eff / TR: 10 / 40 / 3000 ms; RARE factor: 8; NA = 1; temporal 
resolution: 21 s. Identical positions of CBV and BOLD fMRI images were adjusted. The 
native signal intensity (SPre) was estimated prior to the injection of the contrast agent (CA). 
Subsequently, the iron-oxide based CA Endorem (Guerbet, France) was administered via the 
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tail vein at a dose of 33 mg/kg body weight. After an initial wait time of 10 min, allowing 
CA to reach a steady-state, a series of 120 images was acquired over 42 min. Initially the 
CryoProbe thermal shield temperature (Tshield) was adjusted to 30 °C. After acquiring the 
baseline signal for 10 min, the thermal shield temperature was changed to Tshield = 20, 27 or 
38 °C. To maintain the animal’s body temperature at 36.0 ± 0.5 °C the temperature of the 
warm water bath was adapted accordingly. Subsequently, a transition period of 15 min was 
taken into account, allowing the animal to reach constant thermal conditions. For the 
measurements using the RT coil set-up, the identical protocols, procedures and waiting times 
were used, except that, for the post CA scan, a series of only 43 images were acquired over 15 
min 3 sec, as conventional RT coils do not provide the option to change the coil assembly 
temperature, and thus no thermal adaptation of the coil assembly was possible. The animal’s 
body temperature was kept constant at 36.0 ± 0.5 °C using the identical warm water bath set-
up as employed for the CryoProbe measurements.  
Temperature Dependence 
Additional measurements of the temperature on the scalp of the animal were carried out 
using a digital thermometer (Conrad Electronic, Wollerau, Switzerland). These 
measurements served as an estimate for the effective thermal environment experienced by the 
animal when using a conventional RT coil set-up or the CryoProbe at different thermal 
shield temperatures. Following the preparation of the animal, as described above, the scalp 
temperature was measured after an initial stabilization period of 15 min for the RT coil and 
the CryoProbe at 30 °C. When using the CryoProbe, the second measurement of the scalp 
temperature was taken 10 min after adjusting the CryoProbe thermal shield temperature to 
20, 27, or 38 °C. 
Data Analysis 
SNRs were analyzed in both structural spin-echo (RARE) and functional gradient-echo (GE-
EPI) images. For this purpose operator-interactive selection of regions of interest (ROIs) at 
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the left and right somatosensory cortex (S1) areas was performed. Noise levels were estimated 
from the same scans for ROIs selected outside of the subject. 
tSNR was estimated from unstimulated scans acquired in each animal using the first 40 
repetitions (representing, in a fMRI scan using electrical forepaw stimulation, one baseline 
and one stimulation and recovery cycle) as the temporal mean of the S1 signal divided by the 
standard deviation (SD) of the temporal signal course. Prior to analysis, unstimulated scans 
were linearly corrected for slow signal drifts. 
BOLD sensitivity was estimated as the difference between baseline and the maximum BOLD 
signal change of the first stimulation period divided by the SD of the signal in an 
unstimulated scan (Fig. 3-4a, eq.[4]). The maximum BOLD signal changes were tested for 
statistical outliers (data were rejected when exceeding the range: mean ± 2SD) resulting in the 
exclusion of two of 43 scans in total. Statistical analysis of variance (ANOVA) with 
subsequent post hoc comparison of means (Bonferroni) was performed in Origin (Version 
8.0725, OriginLab, Northampton, MA, USA) using a significance level of 0.05. rCBV values 






),               [5] 
where 𝑆?̅?𝑟𝑒 and 𝑆?̅?𝑜𝑠𝑡 represent the average signal intensity prior to CA administration and 
the average steady-state signal after CA administration, respectively. An arbitrary factor of 
100 was used for precision and scaling purposes during visualization. Slow signal drifts 
caused by the washout of the CA were corrected for by fitting a linear function to the initial 
phase after CA administration. Assuming a constant washout of CA during the duration of 
the experiment, the fitted linear function was subtracted from the signal time curve prior to 
rCBV calculation. For the CryoProbe measurements, a second CBV value was estimated by 
calculating 𝑆?̅?𝑜𝑠𝑡 as average signal intensity after a stabilization period of 15 min following 
the change of the CryoProbe thermal shield temperature. 
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3.3 Results 
In initial experiments the accuracy of the pulse angle adjustment based on the fast Bruker 
method and on DAM was compared. Figure 3-1 shows a representative pulse angle map in 
axial view at the level of the S1 areas. The comparison reveals that the Bruker adjustment 
method leads only to a slightly lower pulse angle compared with DAM (Bruker adjustment / 
DAM = 91 ± 2 %). 
 
Figure 3-1: Radiofrequency (RF) pulse angle map in axial view at the level of the somatosensory 
cortex (S1) area (full line) acquired using the double-angle method (target pulse angle, 608). The 
broken line illustrates the positioning of the coronal slice used for fast pulse angle adjustment by the 
Bruker standard procedure. 
 
Anatomical images in coronal view recorded at position 3.7 mm anterior to the interaural 
line (IAL +3.7 mm) covered the somatosensory cortices (Fig. 3-2a, 3-2b). The corresponding 
fMRI images acquired using a GE-EPI sequence displayed good image quality with little 
spatial distortion, which allowed for an unambiguous identification of the somatosensory 
cortices directly on the GE-EPI images (Fig. 3-2d, 3-2e). Structural RARE images were 
analyzed with respect to single image SNR0 (Fig. 3-2c) using ROIs in the somatosensory 
cortex and a region comprising noise (Fig. 3-2a,b), yielding values of 73 ± 7  and 207 ± 11 
(mean ± SD)for RT coil and CryoProbe, respectively. This resulted in a SNR0 gain of 2.84 ± 
0.31 provided by the CryoProbe. Correspondingly, when using a GE-EPI sequence, a SNR0 
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gain of 3.10 ± 0.66 was obtained (x-axis, Fig. 3-2f). In order to investigate the influence of 
physiological noise on the fMRI data, the relationship between tSNR and SNR0 was analyzed 
(Fig. 3-2f). Although, for the RT coil, tSNR (308 ± 93) and SNR0 (289 ± 50) were equal 
within error limits, tSNR (546 ± 243) is significantly reduced (paired sample t-test: p < 
0.001) compared to SNR0 (897 ± 109) for the CryoProbe, which resulted in a tSNR gain by 
the CryoProbe of 1.77 ± 0.96. Linear least-squares fitting of these data according to equation 
3 yielded a λ value of 0.00144 (R2 = 0.94). 
 
Figure 3-2: Anatomical spin-echo (rapid acquisition with relaxation enhancement, RARE) images of 
the mouse brain acquired using room temperature (RT) coil (a) and CryoProbe (b). The broken boxes 
indicate the left and right primary somatosensory cortices (S1), and the filled squares were selected for 
raw image noise estimation. (c) Comparison of image signal-to-noise ratio (SNR0) at the location of 
the S1 area in structural RARE images using region of interest (ROI) selections as indicated in (a) and 
(b). Functional MR images were acquired using a gradient-echo echo planar imaging (GE-EPI) 
sequence with both RT coil (d) and CryoProbe (e). (f) Temporal SNR (tSNR, see section on ‘Data 
analysis’) plotted vs. SNR0 at the location of the S1 area for RT and CryoProbe functional MRI 
(fMRI) data acquired without electrical stimulation. The broken line represents the line of identity, 
and the gray line indicates the result of linear least-squares fitting according to eqn. [3] (λ = 0.00144, 
R2 = 0.94). 
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Figure 3-3: (a) Functional activation maps of representative animals during electrical stimulation of 
the right forepaw acquired using the room temperature (RT) probe and the CryoProbe at Tshield = 20, 
27, 30 and 38 °C. (b) Relative blood oxygen level-dependent (BOLD) signal time curves acquired 
using the RT coil and the CryoProbe with increasing thermal shield temperatures. Error bars indicate 
the standard error of the mean (SEM) for the RT coil (13 scans) and the CryoProbe at Tshield = 20, 27, 
30 and 38 °C (6, 6, 13 and 5 scans, respectively). Dotted lines mark periods of stimulation. 
 
Figure 3-3a shows the activation in the S1 area contralateral to the stimulation side for 
representative animals measured using the conventional RT coil and the CryoProbe at 
increasing thermal shield temperatures, which were found to influence the BOLD signal 
amplitude. Figure 3-3b displays BOLD signal changes for thermal shield temperatures Tshield 
of 20, 27, 30 and 38 °C in comparison with the signal profile acquired using the RT coil, for 
which the temperature could not be adjusted. During all experiments the animal’s body 
temperature was monitored via a rectal probe and kept constant at 36.0 ± 0.5 °C using a 
warm water circuit. Although a signal increase during the stimulation periods of 60 s was 
detected irrespective of the shield temperature, the maximum BOLD signal amplitudes of the 
first stimulation period varied significantly. This effect was investigated in detail by 
estimating BOLD sensitivity from stimulated and unstimulated scans (Fig. 3-4a): Standard 
deviations (σ) of the baseline signal were calculated for each of the unstimulated scans, while 
the maximum BOLD signal changes (ΔS) were derived from the profiles of the stimulated 
scans, respectively. For all Tshield values, reduced noise levels (SD of the unstimulated scan) 
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were found when compared to the RT coil [ANOVA: F(4, 42) = 10.46, p < 0.001]. Post hoc 
comparison of means revealed significant differences between the RT coil and the CryoProbe 
for thermal shield temperatures Tshield of 20, 27, 30, and 38 °C (Fig. 3-4b). The differences in 
σ between RT coil (0.37 ± 0.08 %) and CryoProbe for Tshield = 20 °C (0.23 ± 0.07 %), Tshield = 
27 °C (0.25 ± 0.05 %), Tshield = 30 °C (0.22 ± 0.07 %), and Tshield = 38 °C (0.23 ± 0.02 %) 
were significant, resulting in a decrease of the temporal noise level of the RF electronics by 
factors of 1.63±0.59 (Tshield = 20 °C), 1.49 ± 0.44 (Tshield = 27 °C), 1.65 ± 0.61 (Tshield = 30 °C), 
and 1.59±0.35 (Tshield = 38 °C). There was no effect of the thermal shield temperature on the 
σ value of the baseline signal. 
 
Figure 3-4: Analysis of blood oxygen level-dependent (BOLD) sensitivity (contrast-to-noise ratio, 
CNR). (a) For each animal, CNR values were calculated as the maximum BOLD signal change (DS) 
of the first stimulation period divided by the standard deviation (s) of the first 40 repetitions (gray 
area) of the unstimulated scan acquired in the same animal. Stimulation periods are indicated by the 
dotted line. (b) Comparison of noise level, maximum BOLD signal change and BOLD sensitivity 
between the room temperature (RT) coil and the CryoProbe for increasing thermal shield 
temperatures. Error bars indicate standard deviations over different functional MRI (fMRI) scans. 
Asterisks indicate statistically significant differences of the CryoProbe values at the respective thermal 
shield temperatures in comparison with the RT coil (p<0.05). Comparisons of means between 
CryoProbe values for different thermal shield temperatures are listed in the ‘Results’ section. 
 
The BOLD signal amplitude varied strongly for different Tshield values. Statistical analysis of 
the means revealed a main effect of temperature [ANOVA F(4, 42) = 8.04, p < 0.001]. No 
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significant differences were found for ΔS between RT coil set-up (2.17 ± 1.08 %) and 
CryoProbe at Tshield = 20 °C (1.25 ± 0.17 %, p = 0.268), Tshield = 30 °C (2.79 ± 0.66 %, p = 
0.575) and Tshield = 38 °C (1.86 ± 1.00 %, p = 1.000), but ΔS was significantly higher for 
Tshield = 27 °C (3.62 ± 0.54 %, p = 0.008). Accordingly, a significant effect of temperature was 
found for CNR [ANOVA F(4, 42) = 8.75, p < 0.001]. 
 
Figure 3-5: (a) Body and scalp temperatures, measured in two animals each, when positioned 
under the conventional room temperature (RT) coil and the CryoProbe at increasing thermal 
shield temperatures. The broken line represents the linear regression between the CryoProbe 
thermal shield and scalp temperatures. (b) Relative cerebral blood volumes (rCBV) 
determined in the somatosensory cortex (S1) using either the RT coil or the CryoProbe at 
different thermal shield temperatures. (c) Relationship between maximum blood oxygen 
level-dependent (BOLD) signal change and rCBV. The full line represents linear regression, 
excluding the values obtained for Tshield = 20 °C. Values are given as the mean ± standard deviation. 
 
The dependence of the BOLD signal changes on the CryoProbe thermal shield temperature 
was investigated more thoroughly by (i) measuring the temperature on the scalp (Fig. 3-5a), 
and (ii) measuring rCBV in S1 area to assess baseline perfusion (Fig. 3-5b and 3-5c). 
Although a constant body temperature was maintained for the experiments (36.1 ± 0.5 °C) 
irrespective of Tshield, the scalp temperature depended on CryoProbe thermal shield 
temperature (Fig. 3-5a). Linear regression analysis revealed a linear relationship between Tshield 
and scalp temperature (R2 = 0.99). Scalp temperatures comparable to the RT values (33.4 °C) 
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were found for a CryoProbe thermal shield temperature of Tshield = 38 °C (33.6 °C). Further 
experiments estimating the CBV (eq.[5]) as measure for the baseline perfusion revealed 
comparable values for the RT coil (1.42 ± 0.09) and the CryoProbe at Tshield = 38 °C (1.22 ± 
0.25), and significantly reduced values at Tshield = 20 °C (1.01 ± 0.14), Tshield = 27 °C (0.83 ± 
0.18), and Tshield = 30 °C (1.07 ± 0.16). A significant effect of temperature was found for the 
CBV [ANOVA F(4, 22) = 6.57, p < 0.002]. The relationship between maximum BOLD 
signal change (ΔS) and baseline perfusion (CBV) is depicted in Figure 3-5c. A linear 
relationship (R2 = 0.77) was found between CBV and ΔS when excluding measurement 
values obtained with the CryoProbe at Tshield = 20 °C. Thus, changing Tshield affects CBV 
values with a corresponding impact on the BOLD response. 
3.4 Discussion 
The application of cryogenically cooled RF probes has recently been reported to increase 
SNR in structural in vivo MRI of small animals [35, 36]. However, it has not yet been 
investigated how the SNR gain provided by the cryogenic RF coil translates into sensitivity 
improvements during fMRI studies based on BOLD contrast. The BOLD amplitude elicited 
by sensory input is of the order of a few percent of the baseline signal, and hence fMRI in 
small animals such as mice, remains a challenge, which is commonly accounted for by using 
high magnetic field strength [132] and/or by optimizing sequence parameters [35, 48, 130]. 
The aim of this work was to investigate how increased SNR provided by the CryoProbe [34, 
89] translates into enhanced BOLD sensitivity by comparing fMRI data acquired using 
either CryoProbe or RT coil set-up at the same field strength. 
Analysis of T2-weighted structural images of the mouse brain revealed a SNR gain of a factor 
of 2.8 ± 0.3 for a ROI located within the somatosensory area S1 when using the CryoProbe 
compared with the RT coil set-up. This value exceeds those reported earlier for structural 
mouse brain imaging using identical RF coils as in the present work [36]. The higher value 
can be explained by the superficial location of the ROIs in the S1 area. The slightly larger 
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dimensions of the individual coil elements (arc length) of the RT probe when compared to 
the CryoProbe translate into higher SNR gains for ROIs close to the surface coils [36].  
In fMRI using GE-EPI sequences, a gain of SNR0 of a factor of 3.1 ± 0.7 was found, whereas 
tSNR was degraded by physiological noise resulting in a tSNR gain of 1.8 ± 1.0. However, 
this SNR decrease was less pronounced when compared with values reported in literature 
[89]. Yet, direct comparisons of the absolute SNR with literature remain difficult because of 
different imaging parameters, such as voxel dimensions, sequence timing (TE/TR) and 
different main magnetic field strengths. Increased scattering of tSNR values was observed for 
the CryoProbe relative to the RT coil set-up, revealing the increased sensitivity of the 
CryoProbe to contributions from static and physiological subject noise, as predicted by 
theory (eq. [2]). The variance of the baseline signal was found to be consistently reduced 
when using the CryoProbe as compared to the RT probe irrespective of the thermal shield 
temperature of the CryoProbe. The standard deviation of the baseline signal recorded with 
the CryoProbe was 63 ± 3 % (range 59-67 %) of the corresponding RT values, indicating a 
gain in sensitivity by a factor of 1.60 ± 0.07. When investigating activation patterns over the 
entire brain, the effective gains in SNR0 and tSNR are expected to decrease for deeper brain 
structures due to the surface coil design of the CryoProbe. For the investigation of localized 
activation this effect might be partly compensated for by optimizing pulse angles for the area 
of interest. 
The maximum BOLD amplitude varied as a function of the CryoProbe thermal shield 
temperature (Fig. 3-4b), albeit not significant for all comparisons. We attribute these 
differences to the effects of hypo- or hyperthermia on baseline brain metabolic activity and 
hemodynamics. CBV increases significantly as a function of Tshield in the temperature range 
27 °C < Tshield < 38 °C. At Tshield = 38 °C, thermal conditions (Fig. 3-5a) and CBV values (Fig. 
3-5b) were found comparable to those measured with the RT coil. The baseline CBV values 
affect the BOLD response: high baseline CBV will reduce the capacity of cerebral vessels to 
further dilate on demand. In the range of mild hypothermia (27 °C < Tshield < 38 °C) an 
inverse proportional relation (slope = -2.7 %) was found between the BOLD amplitude and 
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baseline CBV. However, when further lowering the temperature to Tshield = 20 °C (severe 
hypothermia) a strong deviation from this linear relation was observed. Strong hypothermia 
is known to induce a massive reduction of the cerebral metabolic rate and probably affects 
cerebrovascular autoregulatory mechanisms. It has been shown that the relative cerebral 
blood flow is significantly reduced under hypothermic conditions [137]. Under these 
conditions, the system appears to be incapable of adequately responding to the increased 
metabolic and hemodynamic demands associated with excitatory input. 
The temperature dependence of the maximum BOLD signal change emphasizes the 
importance of defined thermal conditions for fMRI studies, as stated previously in earlier 
reports [48]. Although usually only the body temperature of the animal is kept in a narrow 
range, in this work, the local thermal environment of the mouse head can be additionally 
controlled by the CryoProbe thermal shield, an option which is not available for 
conventional RT coils. The CryoProbe shield temperature is a further optimization 
parameter to enhance BOLD sensitivity, though care must be taken to stay within 
physiological limits. 
In conclusion, the consistently lower noise level of the cryogenic surface RF probe leads to an 
increased image SNR (SNR0) and increased temporal SNR (tSNR) compared with a 
conventional RT coil set-up at the same spatial resolution and main magnetic field strength. 
As expected, tSNR was found to be smaller than SNR0, reflecting the impact of physiological 
noise contributions. Furthermore, the comparison of the CryoProbe and the RT coil 
performance with respect to fMRI revealed an increased BOLD sensitivity. Two factors 
contribute to the increase in SNR: the reduction of temporal fluctuations because of 
cryogenic cooling of the RF probe (factor 1.59 ± 0.25 on average over all investigated Tshield) 
and the increased BOLD response as a result of optimized thermal conditions controlled by 
the CryoProbe thermal shield (1.67 ± 0.86 for Tshield = 27 °C). The gain in sensitivity leads to 
increased statistical significance of BOLD-fMRI data, which may be exploited to improve 
temporal or spatial resolution or to study weak BOLD responses. This is of particular interest 
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for fMRI studies in mice, which are becoming increasingly important in view of the large 
number of genetically engineered models of human cerebral pathologies.
 Article submitted: ’’Cannabinoid signaling involved in hyperalgesia caused by local anesthetic lidocaine at 
low doses’’; Simone C. Bosshard, Christof Baltes, Hanns Ulrich Zeilhofer, Markus Rudin  
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4. Cannabinoid Signaling Involved in 
Hyperalgesia Caused by Local Anesthetic 
Lidocaine at Low Doses 
4.1 Introduction 
Sensory and nociceptive processing involves a complex network of neural structures, with the 
first mediator being the nociceptor, a high threshold sensory neuron connecting peripheral 
tissues with the CNS [52]. Substantial progress has been made in understanding the 
molecular mechanisms of normal or pathological pain states, much of it with the help of 
genetically engineered mice displaying altered sensitivity to noxious input [92-95]. 
Lidocaine, a widely used local anesthetic, blocks voltage-gated sodium channels, thereby 
preventing the propagation of action potentials [138]. In clinics, formulations of 1-5 % 
(approx. 35-180 mM) lidocaine are commonly used for inducing regional anesthesia in order 
to suppress pain [139]. In addition, lidocaine has been reported to affect potassium channels 
[140, 141], and Leffler et al. showed the ability of lidocaine to directly activate and sensitize 
the transient receptor potential channel TRPV1 [142]. The capsaicin receptor TRPV1 is 
located on C-fibers and activated by a variety of chemical or physical stimuli [61].  
The purpose of this study was to investigate effects of lidocaine on modulating sensory 
processing in response to noxious stimuli using functional magnetic resonance imaging 
(fMRI) by assessing local changes in cerebral blood oxygenation levels (BOLD [26]) [46]. 
FMRI has been previously used for studying pain processing in humans and rodents, mostly 
in rats [91, 97-101] and recently also in mice [46]. Mice are attractive models as genetically 
engineered mouse lines may yield information on molecular mechanisms involved. We made 
the unexpected observation that pretreatment with lidocaine at concentrations 100x lower 
than those used therapeutically, prompted a robust hyperalgesic effect as reflected both by 
increased BOLD-fMRI responses and behavioral readouts. A recent report suggested a critical 
involvement of type 1 cannabinoid (CB1) receptors in central C-fiber activity-dependent 
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hyperalgesia: the authors provided evidence that activation of CB1 receptors by spinal 
endocannabinoids produced in response to strong noxious stimulation led to a reduction in 
the synaptic inhibition in the dorsal horn and thereby to a sensitization of the nociceptive 
sensory neurons [143]. We therefore hypothesized that the hyperalgesia observed following 
administration of lidocaine at low doses might be centrally mediated by activation of CB1 
receptors located in the dorsal horn of the spinal cord.  To test this hypothesis, we used 
transgenic mice globally lacking the CB1 receptor (CB1-/-) [144]. These animals did not 
display any lidocaine-induced hyperalgesia. These observations were endorsed by an 
experiment with pharmacological inhibition of CB1 receptors: systemic administration of the 
specific CB1 receptor blocker rimonabant (SR 141716) to wild type mice completely 
abolished the lidocaine-induced hyperalgesia. Together, these results indicate that central 
CB1 receptors play a relevant role in mediating the increased sensitization following 
administration of the local anesthetic lidocaine at low doses. 
4.2 Material and Methods  
Animals and Stimulation Paradigm 
All experiments were performed in accordance to the Swiss law of animal protection. 60 
female C57Bl/6J mice and 8 female global CB1-/-, weighing 22 ± 3 g, were used for the 
experiments. The mice were anesthetized with isoflurane (induction 2-3 %, maintenance 1.2 
% in a 70 % air – 30 % oxygen mixture; Abbott, Cham, Switzerland), endotracheally 
intubated, mechanically ventilated and paralyzed (for more details refer to [46]. The tail vein 
was cannulated for drug administration, and body temperature was maintained at 36.5 ± 0.5 
°C using a warm-water circuit integrated into the animal support (Bruker BioSpin AG, 
Fällanden, Switzerland). Heart rate and blood oxygenation were monitored using a MR-
compatible infrared sensor (MouseOx® Pulse Oximeter, Starr Life Sciences, Oakmont, PA, 
USA). For electrical stimulation a pair of needle electrodes (Genuine Grass instruments, 
West Warwick, USA) was inserted subcutaneously into the distal and proximal end of the 
palm of each forepaw, with a distance of 2-3 mm between the two needles. Electrical 
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stimulation was carried out using the following parameters (for details see [46]):  current 
amplitude 1.5 mA, frequency 3 Hz, pulse duration 0.5 ms, stimulation period 60 s (180 
pulses), and resting period 120 s.  
Experimental Groups 
The study design consisted of three sets of experiments: (1) Effects of lidocaine in wild type 
mice: 10 µl of lidocaine hydrochloride dissolved in 0.9 % NaCl was injected into the left 
forepaw 40 min prior to electrical stimulation. The following concentrations were used: 0.15 
mM (n=9), 0.3 mM (n=7), 0.45 mM (n=7), 0.6 mM (n=7), 70 mM (n=6). Saline solution 
(0.9 % NaCl) served as a control and was injected into the right forepaw prior to electrical 
stimulation in all animals. The dynamic von Frey filament test was used to confirm the fMRI 
data (n=6). Baseline measurements of the forepaw withdrawal threshold were recorded in 6 
awake, freely moving mice prior to the injection of 0.3 mM lidocaine under short isoflurane 
anesthesia. The forepaw withdrawal threshold was continuously measured during 60 minutes 
following the lidocaine injection. (2) Effects of lidocaine in CB1-/- mice: electrical stimulation 
(n=8) as described above was carried out first to rule out any differences between the CB1-/-
and the wild type animals without administration of lidocaine. In a second experiment 10 µl 
of 0.3 mM lidocaine and 10 µl of 0.9 % NaCl were injected into the left forepaw and right 
forepaw, respectively, prior to electrical stimulation. (3) Pharmacological inhibition of CB1 
using rimonabant: The CB1 antagonist/inverse agonist rimonabant (SR 141716, Anawa 
trading SA, Wangen, Switzerland) [145] was dissolved in a mixture of ethanol, Cremaphor 
(Sigma-Aldrich, Steinheim, Germany), and 0.9 % NaCl (1:1:18) and administered 
intravenously (10 mg/kg) prior to electrical stimulation only (n=4) or electrical stimulation 
after lidocaine injection (0.3 mM, n=5). For control experiments only the vehicle was 
injected prior to electrical stimulation after lidocaine injection (0.3 mM, n=5).  
MRI Equipment and Sequences 
All MRI experiments were performed on a Bruker BioSpec 94/30 small animal MR system 
(Bruker BioSpin MRI, Ettlingen, Germany) operating at 400 MHz (9.4 Tesla). For signal 
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transmission and reception a commercially available cryogenic quadrature RF surface probe 
(CryoProbe), consisting of a cylinder segment (180° coverage, radius = 10 mm) and 
operating at a temperature of 30 K was used (Bruker BioSpin AG, Fällanden, Switzerland) 
(for detailed information see [36]). Anatomical reference images in coronal and sagittal 
directions (slice orientations are given using the nomenclature of the mouse brain atlas [103]) 
were acquired using a spin echo (Turbo-RARE) sequence with the following parameters: 
field-of-view (FOV) = 20 x 20 mm2, matrix dimension (MD) = 200 x 200, slice thickness 
(STH) = 0.5 mm, interslice distance (ISD) = 0.7 mm, repetition delay TR = 3500 ms, echo 
delay TE = 13 ms, effective echo time TE,eff = 39 ms, RARE factor (number of echoes sampled 
for each excitation) = 32, and number of averages (NA) = 1. The slices for the fMRI 
experiment were planned on the anatomical reference image and BOLD fMRI data were 
acquired using a gradient-echo echo planar imaging (GE-EPI) sequence with the following 
parameters: Five coronal slices covering a range of 2 to 5 mm anterior to the interaural line 
(IAL +2-5 mm) were recorded with FOV = 23.7 x 12.0 mm2, MD = 90 x 60 (acquisition) 
and 128 x 64 (reconstruction) yielding an in-plane resolution of 200 x 200 µm2, STH = 0.5 
mm, ISD = 0.7 mm, TR = 2500 ms, TE = 8.5 ms, and NA = 3 resulting in an image 
acquisition time of 7.5 seconds. One fMRI experiment consisted of 112 or 152 repetitions 
and lasted 14 or 19 min. 
Data Analysis and Statistics 
The general linear model (GLM) tool integrated in the Biomap software program (M. 
Rausch, Novartis, Switzerland) was used to calculate statistical t-maps. GLM assesses 
correlations on a pixel-by-pixel basis between the fMRI signal and the stimulation pattern. 
The statistical threshold to detect activation was set to p=0.0001 for all experiments. Two 
coronal sections (IAL +2.8 mm and IAL +3.7 mm) covering the primary and secondary 
somatosensory cortices, the thalamus and the insula, were analyzed using a minimal cluster 
size of 15 voxels. The respective regions-of-interests (ROIs) derived from the GLM analyses 
were used to extract BOLD signal changes as a function of time. In cases for which the 
correlation analysis revealed no activated voxels, ROIs were transferred from the mouse brain 
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atlas [103]. EPI images covering the S1 area (IAL +3.7 mm) were used for group analysis as 
described in [46]. Comparative statistics was performed taking the maximal BOLD value of 
the first stimulation period of each animal. Values were not normally distributed and 
therefore tested at the α = 0.05 level using the non-parametric Kruskal-Wallis test followed 
by the post hoc Fisher test (comparison between different groups). All values are presented as 
mean ± SEM.  
Behavioral Test: Von Frey Filaments 
The behavioral testing was made in 6 wild type mice, which were kept in the test cages for 
one hour prior to testing to allow accommodation. For baseline recording, each mouse was 
tested on each forepaw to obtain at least 5 data points measuring paw withdrawal thresholds 
to stimulation with electronically controlled von Frey filaments. Another baseline of 3 
measurements per paw per mouse was recorded before injection of 10 µL 0.3 mM lidocaine 
into both forepaws. This was done under short isoflurane anesthesia (2 %, 1-2 min), after 
which the animals were put back to the test boxes. Only 4 animals received lidocaine 
injections, the other two received sham injections to serve as controls. The observer was blind 
to the treatment of the mice. Measurements were taken during 60 min after lidocaine 
injection in all animals. Values were averaged for intervals of 10 min and are presented as 
mean ± SEM.   
4.3 Results 
Pretreatment with Low Doses of Lidocaine Causes Hyperalgesia 
Electrical stimulation of the forepaw using a current amplitude of 1.5 mA was shown to 
activate brain areas attributed to the pain matrix [46]. Consistent BOLD responses (in > 95 
% of all animals studied) have been observed in the areas of the primary and secondary 
somatosensory cortices (S1 and S2), the thalamus and the insular cortex as revealed by 
general linear model (GLM) analysis (Fig 1a). The temporal changes of the BOLD amplitude 
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in the regions involved corresponded well with the four stimulation periods (Fig. 4-1b for S1 
area contralateral to the stimulated paw). Non-invasive physiological monitoring of the mice 
showed stable parameters throughout the entire experiment: no changes in body temperature 
(36.5 ± 0.5 °C), arterial O2 saturation (> 98 %), or heart rate (approx. 500 beats per minute) 
could be detected during the stimulation periods.  
 
Figure 4-1: (a) Activation maps of the cortex after left and right electrical forepaw stimulation of 1.5 
mA. Data show activated regions derived from GLM analysis (p = 0.000001, cluster size 15 voxels) for 
all animals overlaid on the mouse brain atlas at IAL +3.7 mm. The intensity indicates the number of 
animals showing significant BOLD activation at the given threshold. Scale bar is adjusted to the total 
number of scans performed. Bottom left: Mouse brain atlas overlaid on the anatomical MR image. 
Red indicates the forepaw region of the S1 somatosensory cortex. (b) Temporal profile of the relative 
change of the BOLD signal intensity as observed in the contralateral S1 area during electrical forepaw 
stimulation. Traces show electrical stimulation only (black), after injection of 0.3 mM lidocaine (dark 
gray) and after injection of 70 mM lidocaine (light gray). Grey bars indicate stimulation periods. All 
values are indicated as mean ± SEM. 
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Local administration of low concentrations of lidocaine into the mouse forepaw 40 min prior 
to the fMRI study led to a significant increase of the maximum BOLD signal change as 
compared with the untreated forepaw stimulated at the same current amplitude. 
 
Figure 4-2: (a) Maximum BOLD signal changes in the S1 contralateral to the stimulated paw and in 
the thalamus in naïve WT animals and animals pretreated with lidocaine or NaCl. All values are 
indicated as mean ± SEM. (*p < 0.05, #p < 0.05 compared to all other groups). (b) Withdrawal 
threshold of the forepaws measured with dynamic von Frey filaments after injection of 0.3 mM 
lidocaine. An increased sensitivity was observed up to 30 min after lidocaine injection. All values are 
indicated as mean ± SEM. (*p < 0.05).  
 The maximal BOLD signal change (in % of baseline values) in the S1 region contralateral to 
the stimulated paw in naïve animals was 2.65 ± 0.2 % (Fig. 4-1b, Fig. 4-2a). This differed 
significantly from the maximal BOLD values of 4.89 ± 0.6 % (p = 0.0003), 3.96 ± 0.6 % (p 
= 0.03), and 4.01 ± 0.7 % (p = 0.02) for 0.3, 0.45, and 0.6 mM (10 µl) lidocaine, 
respectively, except for the lowest concentration used (0.15 mM), for which a value of 3.71 ± 
0.4 % (p = 0.06) has been obtained. The BOLD response was dose-dependent with a 
maximum effect at 0.3 mM lidocaine (Fig. 4-2a). Clinically relevant doses (70 mM, 2 %) of 
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lidocaine almost completely abolished the BOLD signal (0.67 ± 0.2 %; Fig. 4-1b, Fig. 4-2a)). 
Activation maps for the 70 mM lidocaine group derived from GLM analysis (using p = 10-6 
as threshold) showed weak activation in the S1 area with clearly decreased intensity and 
extent as compared with the untreated and low dose lidocaine-treated groups (Fig. 4-1a). 
Injection of the vehicle (0.9 % NaCl) led to a maximal BOLD signal change of 3.37 ± 0.3 
%, which was not significantly different from the untreated animals (p = 0.16), but 
significantly smaller than the response following administration of 0.3 mM lidocaine 
(p=0.02; Fig. 4-2a). The dependence on the lidocaine dose and the lack of response to the 
vehicle administration indicate that the increased sensitivity is caused by the local anesthetic 
administered at low concentrations. To further validate these unexpected fMRI findings we 
assessed the sensitivity of the mice in response to mechanical stimulation of the injected paw 
with von Frey filaments. The forepaw baseline withdrawal threshold of 1.0 ± 0.04 g was 
reduced significantly to 0.18 ± 0.05 g (p = 0.0002) 10 min and to 0.5 ± 0.09 g (p = 0.00007) 
30 min after injection of 0.3 mM lidocaine. The hyperalgesic effect lasted for 30 min in the 
awake and moving animals before values slowly returned to baseline levels (Fig. 4-2b).  
Lidocaine-Induced Hyperalgesia Requires the Type 1 Cannabinoid Receptor (CB1) 
In global CB1 knock-out mice (CB1-/-) electrical stimulation of the forepaw at 1.5 mA yielded 
a maximal BOLD signal change of 2.28 ± 0.2 % in the S1 contralateral to the stimulated 
 
Figure 4-3: Maximum BOLD signal changes in the S1 contralateral to the stimulated paw and in the 
thalamus comparing WT (gray bars) and CB1-/- (black bars) with or without lidocaine pretreatment. 
All values are indicated as mean ± SEM. (*p < 0.05) 
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paw, indicating no difference of sensitivity as compared with the WT animals (p = 0.39). 
However, following pretreatment of the forepaws with 0.3 mM lidocaine (10 µL), CB1-/- did 
not show the hyperalgesic response observed in WT animals. The maximal BOLD values 
were 3.11 ± 0.8 % in CB1-/- versus 4.89 ± 0.6 % in WT, respectively, which was statistically 
significantly different (p = 0.006). In contrast there was no difference in BOLD signal 
amplitudes in CB1-/- mice with and without lidocaine treatment (p = 0.15). Also, injection of 
10 µl NaCl into the forepaw of the CB1-/- mice did not affect the maximal BOLD signal 
change (1.76 ± 0.4 %, p = 0.40) (Fig. 4-3).  
 
Figure 4-4: (a) Maximum BOLD signal changes in the S1 contralateral to the stimulated paw and in 
the thalamus of WT animals (naïve or pretreated with lidocaine and/or the CB1-blocker rimonabant). 
(b) Correlation of the maximum BOLD signal changes in the thalamus and the S1 contralateral to the 
stimulated paw. (Squares: Lidocaine treatment, black: WT, white: CB1-/-, dark gray: Rimonabant 
(vehicle), light gray: NaCl). All values are indicated as mean ± SEM. (*p < 0.05) 
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The involvement of the CB1 receptor in eliciting the hyperalgesic response to lidocaine was 
confirmed by pharmacological inhibition of CB1 receptors using the selective 
antagonist/inverse agonist rimonabant. In the absence of lidocaine, rimonabant did not affect 
the BOLD signal change (3.06 ± 0.4 % versus 2.65 ± 0.2 % without rimonabant, p = 0.39) 
in response to electrical stimulation. Systemic administration of rimonabant following 
pretreatment with 0.3 mM lidocaine completely abolished the hyperalgesic effects of 
lidocaine (3.20 ± 0.5 % compared to 4.88 ± 0.6 % with and without rimonabant, p = 0.01). 
In contrast, administration of the rimonabant vehicle did not affect the hyperalgesic reaction 
to low dose lidocaine and led to a maximal BOLD signal change of 4.53 ± 0.3 %, which is 
comparable to the values observed following application of lidocaine alone (4.88 ± 0.6 %, p = 
0.55), but is significantly different from the application of rimonabant combined with 
lidocaine (p = 0.04) (Fig. 4-4a).  
For all experiments, the BOLD signal changes in the thalamus showed trends that are in line 
with the changes observed in the S1 region contralateral to the stimulated paw. This is 
reflected by the good correlation (R2 = 0.8) of the BOLD responses of the two regions (Fig. 
4-4b). 
4.4 Discussion 
Functional MRI in small animals has become an important tool in biomedical research, as it 
provides global insight of brain activation while being non-invasive allowing the coverage of 
large brain volumes. Studies in humans and animals showed noxious-evoked activation 
patterns to correspond with the structures of the pain matrix [46, 97-101]; hence, fMRI 
allows studying aspects of pain processing non-invasively. However, due to the hemodynamic 
origin of the signal, the activated areas are usually not tightly confined to the functional brain 
entities but include territories covered by irrigating and draining vessels. Correspondingly, 
the activated areas in mouse brain identified by fMRI correlation analysis extend beyond the 
functional maps of the brain atlas (Fig. 4-1a) [103].  
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Lidocaine is a widely used local anesthetic and antiarrhythmic agent, which acts through 
inhibition of the voltage-gated Na+ channels. Voltage-gated Na+ channels play a crucial role 
in the generation and propagation of action potentials. Blocking Na+ channels by lidocaine 
has been investigated in neurons and in the heart by various methods [146-148].  
Unexpectedly, administration of lidocaine at low dose caused significant and reproducible 
hyperalgesia, a rather surprising observation for a compound clinically used for analgesia. 
While the BOLD response to paw stimulation following pretreatment with lidocaine at a 
dose of 2 % (70 mM) lidocaine, which is commonly used for local anesthesia, was almost 
completely suppressed, concentrations of lidocaine in the range 0.15 to 0.6 mM elicited a 
significant increase in local brain activity as reflected both by an increased amplitude and 
extent of the BOLD signal. Experiments using the behavioral von Frey filament test revealed 
that these observations were not an artifact of the fMRI experiment but rather reflected 
hyperalgesia. This sensitization following lidocaine injection could be reproduced in all 
animals studied. The effect did not last quite as long as in the fMRI experiments, which is 
most likely due to the fact that the mice in the behavioral test were awake and moving, while 
the animals in the fMRI experiments were anesthetized for the entire duration of the 
experiment. The underlying mechanisms acting in the sensory afferents are not entirely 
understood. Experiments with injection of NaCl indicate a slight, though not significant, 
increase of the BOLD response, which largely excludes the increased amount of liquid and 
electrolytes in the paw, which might alter the electrical conductivity, to be the cause for the 
hyperalgesic response observed.  
Several mechanisms might account for the initial nociceptive input, which triggers the 
secondary hyperalgesic effect observed in the fMRI experiments following administration of 
lidocaine at a low dose. It has been shown that lidocaine activates and sensitizes the TRPV1 
receptors and thereby directly activates C-fibers, at concentrations exceeding 1 mM [142]. 
However, as the concentrations used in this study are up to 10-fold smaller, activation of C-
fiber signaling through lidocaine binding to TRPV1 channels appears unlikely. Another 
possibility might be the blocking of K+ channels, which already occurs at much smaller 
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lidocaine concentrations than required for the blocking of Na+ channels, and therefore might 
lead to a change in the excitability of these neurons and to an enhanced sensitivity to noxious 
input. This would be in line with reports on the enhancement of delayed-rectifier K+ currents 
at <0.1 mM lidocaine and a partial channel block at concentrations >0.1 mM [141].  
Independent of these potential peripheral mechanisms leading to a sensitization, central 
mechanisms have to be considered as well. Based on a recent report [143], we hypothesized 
that injection of lidocaine might lead to an activity-dependent endocannabinoid-mediated 
secondary hyperalgesia. Pernia-Andrade et al. demonstrated the activation of CB1 receptors of 
the dorsal horn in the spinal cord during strong nociceptive (C-fiber) input [143]. This 
would then cause a disinhibition of the pain-specific neurons in the dorsal horn, which are 
rendered sensitive to input even from non-nociceptive A-fibers, thereby resulting in 
hyperalgesia in the area surrounding the original nociceptive input. The observation that in 
CB1-/- mice the BOLD response to electrical stimulation was not affected by administration 
of 0.3 mM lidocaine (the concentration that elicited the largest effect in WT animals) and 
that the lidocaine induced hyperalgesic affect could be completely inhibited by 
administration of CB1-blocker rimonabant, clearly prove an involvement of the 
endocannabinoid system in the development of hyperalgesia due to injection of low 
concentrations of lidocaine prior to electrical stimulation. Additional studies are warranted to 
elucidate molecular mechanisms underlying this phenomenon.  
Another report by Fioravanti et al. [149] may also be of interest in this context linking the 
CB1 receptors to the TRPV1 channel on nociceptors. It has been shown that in cells 
coexpressing CB1 and TRPV1, CB1 activation either inhibits or stimulates TRPV1 
depending on the activation of the cAMP cascade [150]. Fioravanti et al. have shown that the 
TRPV1 channel remains in a sensitized state induced by tonic activity of the CB1 receptor 
[149], which would be in line with enhanced sensitivity to sensory input. This mechanism 
should also be considered when trying to resolve the processes underlying the sensitization 
induced by lidocaine as observed in this study.  
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Of course one has to consider that fMRI studies are typically carried out in anesthetized 
animals, a recurring issue, in particular when investigating nociception.  Ideally, anesthesia 
should neither interfere with brain activity nor act analgesic. However, many anesthetics 
suitable for longitudinal studies have an analgesic component and some even affect the 
neurovascular coupling. We used isoflurane in this study as it allows easy administration and 
controlled dosing. In previous studies, we [46] and others [71, 73, 151] have shown that 
robust and reproducible fMRI signals can be obtained in response to sensory and noxious 
stimuli. In the latter case significant activation has been observed in brain areas involved in 
pain processing, indicating the feasibility of such studies using this anesthesia protocol.  
Aside from the mechanistic implications, the findings of our study might also be of clinical 
relevance. In spite of the higher concentrations of lidocaine applied clinically, there will be 
regions in the boundary area of the infiltrated tissue, in which concentrations are as low as 
the ones used in this study. Similarly, in the course of drug wash-out and degradation low 
concentrations will inevitably occur. The observation that such low concentrations can cause 
a sensitization could partially account for postsurgical hyperalgesia. 
 * The NaV1.7R-/- mice were kindly provided by Prof. Dr. John Wood, University College 
London, UK.  
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5. Reduced BOLD Response in Mice Lacking 
Nociceptor Specific Sodium Channels (NaV1.7)  
5.1 Introduction 
Voltage-gated sodium channels are integral membrane proteins found in neurons and most 
other electrically excitable cells. They are responsible for the rising phase of the action 
potential, and contain nine structurally related α-subunits that form sodium selective aqueous 
pores in the cell membrane [152, 153]. Pharmacologically, the sodium channel subtypes can 
be distinguished by their sensitivity to tetrodotoxin (TTX), a neurotoxin isolated from the 
puffer fish and other members of the order of Tetraodontiformes. The larger group comprises 
the so called TTX-sensitive channels which are blocked by nanomolar concentrations of 
TTX, while the TTX-resistant channels cannot be blocked by micromolar concentrations of 
TTX [154]. The role of sodium channels in pain pathways has become increasingly 
important due to alterations of the proteins that occur in pain states [155-157].       
The TTX-sensitive sodium channel NaV1.7, which is located at the terminal of small-
diameter sensory neurons, plays an important role in pain mechanisms. Studies with 
nociceptor specific knock-out mice (NaV1.7R-/-) revealed a reduction in mechanosensation, a 
strong deficit in the development of inflammatory pain, and hyposensitivity to noxious 
thermal stimulation as measured with the Hargreave’s apparatus [94]. 
After the development of a robust stimulation paradigm to study pain processing in mice 
using BOLD fMRI [46], we tested for its specificity by applying the paradigm to NaV1.7R-/- * 
mice.    
5.2 Methods 
Three groups of animals were examined for this study: (i) the wild type (WT) group 
consisted of 8 female C57Bl/6 mice of 3-6 months of age. (ii) The NaV1.7R-/- group 
consisted of 6 animals, 4 males and 2 females, aged 2-8 months. (iii) The WT littermates of 
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the NaV1.7R-/- mice consisted of 2 females and 3 males, aged 2-8 months. The NaV1.7R-/- 
and their WT littermates were kindly provided by Dr. John N. Wood, University College 
London, United Kingdom.  
Preparation of the animals included intubation and mechanical ventilation, stereotactic 
fixation of the head, and monitoring of body temperature and blood gas levels. The 
experiments were performed under isoflurane anesthesia. The stimulation consisted of 
sequential bilateral forepaw stimulation using a stimulation amplitude of 1.5 mA. A detailed 
description of preparation, stimulation, MR parameters, and data analysis is available in 
Chapter 2.2 and [46]. 
5.3 Results 
 
Figure 5-1: Statistical t-maps (2D low pass filtered) obtained with GLM analysis of two representative 
animals: (a) NaV1.7R-/-; (b) WT. Statistical maps are overlaid on the EPI image, showing activation 
after stimulation of the left forepaw. T-values are indicated at the scale bar. 
Electrical forepaw stimulation led to a statistically significant BOLD signal change in all 
experimental groups. Distinct activation was detected in the somatosensory cortex ipsi- and 
contralateral (Fig. 4-1) to the stimulated paw and in the thalamus. While the temporal 
profiles of the WT and WT littermates are virtually identical, the NaV1.7R-/- mice display a 
significantly reduced BOLD response (Fig. 4-2). The maximal BOLD signal changes of the 
somatosensory cortex contralateral to the stimulated paw were 1.3 ± 0.4 % (NaV1.7R-/-), 2.54 
± 0.2 % (WT) and 2.03 ± 0.3 % (WT littermates).  
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Figure 5-2: Relative change of BOLD signal in contralateral somatosensory S1 area during electrical 
forepaw stimulation at 1.5 mA for the Nav1.7R-/- (dark blue, n=6), WT littermates (blue, n=5) and the 
WT animals (light blue, n=8). Black bars indicate stimulation periods. All values are presented as 
mean+SEM. 
The values of the integrated BOLD profiles of the contralateral somatosensory cortex (120 s 
– 180 s) yielded 111.2 ± 28 %s, 224.1 ± 43 %s, and 232.2 ± 21 %s for the NaV1.7R-/-, WT 
littermates and WT mice, respectively (Fig. 4-3). The values for the NaV1.7R-/- were 
significantly different compared to the WT littermates (p = 0.04) and the WT mice (p = 
0.01).  
 
Figure 5-3: Areas under the curve of the S1 area contralateral to the stimulated paw and the thalamus, 
integrated during the four stimulation periods. All values are presented as mean ± SEM. Asterisks 
indicate a significant difference at the 0.05 level. 
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For the thalamus, the situation is less clear: The maximal BOLD amplitudes are 1.76 ± 0.26 
% for the WT animals, 0.74 ± 0.22 % and 0.76 ± 0.33 % for the WT littermates and the 
NaV1.7R-/-, respectively. The integral values for the NaV1.7R-/- (27.8 ± 20 %s) are 
significantly smaller than those of the WT animals (196.1 ± 36 %s, p = 0.0006). However, 
the values of the WT littermates were also quite low (89.2 ± 24 %s), but not significantly 
different compared to either of the other groups.  
5.4 Discussion 
Electrical stimulation of the forepaws using a current amplitude of 1.5 mA led to robust and 
reproducible BOLD signal changes in brain areas associated with nociception (somatosensory 
cortices, thalamus). As expected, the cortical and thalamic BOLD response was significantly 
reduced in NaV1.7R-/- mice. This is in line with behavioral data reported for these mice, 
which show a dramatic reduction in mechanosensation [94]. However, electrical stimulation 
of the forepaw might not be the ideal paradigm to test for nociception and its pathologies 
due to different reasons: 1) it is difficult to determine whether the stimulation using certain 
parameters is noxious or still innocuous, since the intensity depends on the current density in 
the tissue. Due to the experiments described in chapter 2.2 we believe that the stimulation 
used in this study is noxious and therefore recruits predominantly Aδ- and C-fibers. 2) It is 
not possible to discriminate whether the detected fMRI signal in the brain is only related to 
the noxious stimulation or due to direct electrical activation of the primary afferents, which 
include Aβ-, Aδ- and C-fibers. Direct electrical activation of the afferents might explain why 
we still detect a BOLD signal change of more than 1 % in the NaV1.7R-/- mice, despite the 
lack of the NaV1.7 sodium channels which should inhibit signal transmission on nociceptors. 
Therefore, it will be of interest to test these mice with the strictly noxious thermal 
stimulation paradigm described in chapter 6. 
The results obtained of the thalamus are not in good agreement with the cortex data. The 
BOLD signal of the NaV1.7R-/- is still markedly reduced as compared to the WT animals. 
However, the BOLD signal of the WT littermates is also reduced in comparison to the WT 
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animals, with a maximum amplitude in the range of the NaV1.7R-/- mice. The reason for the 
decreased thalamus activation needs to be determined in further studies.    
 Article in preparation: ’’TRPV1-Mediated Entry of the Quaternary Lidocaine Derivative QX–314 Leads 
to Inhibition of Nociceptive Input as Measured by BOLD fMRI in Mice Using Thermal Stimulation’’; 
Simone C. Bosshard, Florian Stuker, Constantin von Deuster, Markus Rudin.  
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6. TRPV1-Mediated Entry of the Quaternary 
Lidocaine Derivative QX–314 Leads to 
Inhibition of Nociceptive Input as Measured 
by BOLD fMRI in Mice Using Thermal 
Stimulation 
6.1 Introduction 
Functional magnetic resonance imaging (fMRI) in animals enables non-invasive studies of 
brain function, e.g. involving the sensory system. Electrical stimulation is a commonly used 
stimulation paradigm for such studies [70-72, 91, 102] and has recently been applied to 
analyze sensory and nociceptive processing in mice [46]. However, there are several 
drawbacks to this type of stimulation besides the fact that it is not physiological: 1) the 
needle electrodes need to be inserted subcutaneously into the skin, which induces a stimulus 
even in the absence of an electric current. 2) The stimulus strength is determined by the local 
current density, which depends on the (relative) placement of the electrodes. 3) The electrical 
current may activate the neurons directly instead of only inducing a peripheral stimulus, 
which then leads to the activation of neurons. In view of these drawbacks, we aimed at 
establishing a physiological stimulation paradigm with better controllable parameters suitable 
for fMRI studies. We adopted noxious stimulation by local heating of the forepaws using an 
infrared laser source operating at 975 nm. Our data show that this protocol leads to 
reproducible changes in the blood oxygen level dependent (BOLD) signal intensity in the 
various brain areas associated with the pain processing as a function of temperature. 
Pain sensation caused by heat is mediated by receptors of the transient receptor potential 
(TRP) family, the most important being the vanilloid receptor TRPV1, which is activated by 
temperatures of 42 °C and above [61] and located on C-fiber afferents [158]. Other members 
of the TRP family respond to similar (TRPV3, activation threshold: 33-39 °C, into noxious 
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range,) or higher (TRPV2, activation: 52 °C) temperatures [159, 160]. TRPV2 channels 
were reported to activate thinly myelinated Aδ-fibers [161, 162], whereas TRPV3 channels 
are only located in keratinocytes in mice [160], but not in dorsal root ganglia (DRGs). 
To demonstrate the specificity of the paradigm for assessing nociceptive signaling we applied 
the quaternary lidocaine derivative QX-314 (lidocaine N-ethyl chloride) to the forepaws. 
QX-314 is a permanently positively charged molecule which, due to its charge, cannot cross 
cell membranes. The compound has no effect on sodium channels when applied 
extracellularly, however, intracellularly applied, it was found to block sodium channels, 
leading to local anesthesia [163-166]. Binshtok and colleagues established a method to 
selectively block nociceptive signaling by activating TRPV1 channels; Also known as 
capsaicin receptor, TRPV1 is located on C-fiber nociceptors and activated by a wide range of 
physical and chemical stimuli, among them capsaicin [61]. Binding of capsaicin activates and 
opens the TRPV1 channel, allowing the QX-314 molecule to enter the cell and block the 
sodium channels from the inside, inhibiting the propagation of action potentials [167].  
Indeed, in this fMRI study we showed that application of QX-314 in combination with 
capsaicin led to an abolishment of the BOLD signal in response to the thermal stimulation, 
while administration of either compound alone did not affect the signal amplitude.  
6.2 Methods 
Animal Preparation 
All experiments were performed in accordance with the Swiss law of animal protection. 20 
female C57Bl/6 mice weighing 22 ± 3 g were anesthetized with isoflurane (induction 2-3 %, 
maintenance 1.2 % in a 70 % air – 30 % oxygen mixture; Abbott, Cham, Switzerland), 
endotracheally intubated and mechanically ventilated throughout the entire experiment. 
Further preparation included stereotactic fixation of the head, monitoring of body 
temperature, heart rate and arterial oxygen saturation; and administration of a neuromuscular 
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blocking agent. Most animals were used for more than one experiment. For more detailed 
information on animal preparation please refer to Chapter 2.2 and [46].  
Non-invasive monitoring of the mice showed stable physiology throughout the experiments. 
Body temperature was kept stable at 36.5 ± 0.5 °C for the entire experiment. Heart rate was 
stable around 500 beats per minute in all animals and did not change during stimulation. 
Arterial oxygen saturation was > 97 %, indicating a well adjusted ventilation of the animals. 
After completion of the fMRI experiments, the animals recovered fast and could be used for 
further experiments.  
Experimental Groups 
For the implementation and optimization of thermal stimulation paradigm three conditions 
have been evaluated: (Group 1) Stimulation at 45 °C using a 2 mm diameter laser spot 
(nanimals = 10, nscans = 19). (Group 2) Stimulation at 46 °C using a 2 mm diameter laser spot 
(nanimals = 6, nscans = 11). (Group 3) Stimulation at 45 °C using a laser spot of 1 mm in 
diameter (nanimals = 6, nscans = 12).  
Using the paradigm yielding the maximal BOLD signal with no obvious side effects due to 
heat stimulation (corresponding to 45 °C using a 2 mm diameter laser spot), the specificity of 
the protocol was evaluated using pharmacological modulation of the thermal stimulation. 
Again three groups of animals have been used:  (Group 4) Animals receiving an injection of 
10 µl of a solution containing 67 mM QX-314 and 1.6 mM capsaicin locally into the left 
and right forepaw 80 and 100 min before thermal stimulation, respectively (nanimals = 7, nscans = 
14). The mixture was prepared from stock solutions  of  5 µl QX-314 (134 mM, lidocaine 
N-ethyl chloride, Sigma-Aldrich, Steinheim, Germany) dissolved in 0.9 % NaCl and 5 µl 
capsaicin (3.3 mM, Sigma-Aldrich, Steinheim, Germany)  dissolved in ethanol and diluted 
with 0.9 % NaCl. 
Two control groups have been used: (Group 5) Animals receiving 10 µl of 67 mM QX-314 
in 0.9 % NaCl into the left and right forepaw 80 and 100 minutes prior to thermal 
stimulation, respectively (nanimals = 3, nscans = 6), and (Group 6) mice receiving10 µl solution 
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containing 1.6 mM capsaicin dissolved in ethanol and 0.9 % NaCl into the left and right 
forepaw 80 and 100 minutes before stimulation (nanimals = 3, nscans = 6).    
Thermal Stimulation 
Thermal stimulation was performed using a custom built stimulation device consisting of the 
following parts: two 9 W infrared laser diodes operating at 975 nm (BMU8_975_01_R, 
Oclaro, San Jose, CA, USA) were connected to 5 m glass fibers (Thorlabs Inc., München, 
Germany) which entered the Faraday cage of the scanner. The power output of the laser was 
regulated by a custom built driver (Meerstetter Engineering GmbH, Rubigen, Switzerland). 
Two types of cubes made from black plexiglas with a small hole drilled in the center (1 or 2 
mm) were mounted on the SMA connector at end of the glass fibers, allowing choosing 
between two different diameters of the laser spot (1 or 2 mm) (Fig. 6-1b). In addition, a 
temperature probe was placed next to the bore to record the temperature of the paw (Fig. 6-
1b). The temperature probe was connected to an electrical thermometer (P600, Dostman 
Electronic, Wertheim-Reicholzheim, Germany). The homebuilt proportional-integral-
derivative (PID) controller was used as a feedback control, regulating the laser driver in order 
to maintain the measured temperature at the paw at the set target temperature. The 
stimulation paradigm was controlled from the physiological monitoring device (Powerlab, 
ADInstruments, Spechbach, Germany), sending a trigger pulse to the PID controller (Fig. 6-
1a). 
The stimulation paradigm consisted of a block design starting with a resting period of 120 s 
(baseline) followed by 60 s of stimulation. This series was repeated four times and fMRI data 
acquisition was continued for another seven minutes after the last stimulation block. A 
stimulation experiment was considered successful if the target temperature at the paw was 
maintained for at least 30 s with an accuracy of ± 0.5 °C. Stimulation started with the left 
paw in all animals. Following a resting period of 8 minutes, the right paw was stimulated.  
The feedback controlled temperature regulation of the laser worked reliable for both spot 
diameters. On average 20-25 s were used to reach the target temperature, which was 
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maintained for the remainder of the stimulation period with ± 0.5 °C deviation at the most 
(Fig. 6-1c). Only 2 out of 64 scans had to be discarded because the target temperature was 
not reached within 30 s.  
 
Figure 6-1: (a) Set-up of the laser stimulation with temperature-feedback-loop. (b) Close-up of the 
plexiglas cube and temperature control placed at the paw; the hole allowed using two spot diameters (1 
and 2 mm). (c) Temperatures during stimulation, recorded at the mouse forepaw for three different 
scans. Target temperature of 45 ± 0.5 °C was reached for at least 30 s.   
 
MRI Equipment and Sequences 
All experiments were carried out on a Bruker BioSpec 94/30 small animal MR system 
(Bruker BioSpin MRI, Ettlingen, Germany) operating at 400 MHz (9.4 Tesla). For signal 
transmission and reception a commercially available cryogenic quadrature RF surface probe 
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(CryoProbe) operating at 30 K was used (Bruker BioSpin AG, Fällanden, Switzerland) (for 
detailed information see [36]). The ceramic outer surface of the coil touching the mouse head 
was kept at 30 °C using a temperature-controlled heating device.  
Anatomical reference images in coronal and sagittal directions (slice orientations are given 
using the nomenclature of the mouse brain atlas [103]) were acquired using a spin-echo 
(Turbo-RARE) sequence (for detailed parameters see Chapter 2.2 and [46]). Subsequently, 
the slices for the fMRI experiment were planned on the anatomical reference images and 
BOLD fMRI data were acquired using a gradient-echo echo planar imaging (GE-EPI) 
sequence with the following parameters: Five coronal slices covering a range of 2 to 5 mm 
anterior to the interaural line were recorded with a field-of-view FOV = 23.7 x 12.0 mm2, 
matrix dimension MD = 90 x 60 (acquisition) and 128 x 64 (reconstruction), yielding an in-
plane resolution of 200 x 200 µm2, slice thickness STH = 0.5 mm, interslice distance ISD = 
0.7 mm. For the optimization experiments (1) and (2), values for repetition time TR = 2500 
ms, echo time TE = 8.5 ms, number of averages NA = 3, and number of repetitions NR = 
152 have been used, resulting in an image acquisition time of 7.5 seconds. For all remaining 
experiments, the parameters were as follows: TR = 1000 ms, TE = 8.5 ms, NA = 1 and NR = 
1140, resulting in a temporal resolution of 1 second. All fMRI acquisitions lasted 19 min. 
Data Analysis and Statistics 
Data analysis was performed using the Biomap software program (M. Rausch, Novartis 
Institute for Biomedical Research, Switzerland). Statistical t-maps were calculated using the 
general linear model (GLM) tool, which assesses correlations on a pixel-by-pixel basis 
between the fMRI signal train and the stimulation paradigm. Activation was detected using a 
statistical threshold of p = 0.0001 for all experiments. With a minimal cluster size of 15 
voxels, two coronal sections were analyzed, of which one slice covered the thalamus, the 
secondary somatosensory (S2) and insular cortex (IC) (2.8 mm anterior to the interaural line 
(IAL + 2.8 mm)), and the other covered the forepaw areas of the primary somatosensory 
cortex (S1) (IAL + 3.7 mm). The respective regions-of-interest (ROIs) derived from the 
GLM analyses were used to extract the BOLD signal changes as a function of time. In cases 
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for which the correlation analysis revealed no activated voxels at the expected locations, ROIs 
were transferred from the mouse brain atlas [103]. In addition to these regions, a control 
region located at the ventral pallidum and not involved in nociceptive processing was 
evaluated. GLM-derived activation patterns (EPI images covering the S1 area (IAL +3.7 
mm)) were used for group analysis as described in [46]. 
Comparative statistics was performed taking the maximal BOLD value of the first 
stimulation period of each animal. Values were not normally distributed and therefore tested 
at the α = 0.05 level using the non-parametric Kruskal-Wallis test followed by the post hoc 
Bonferroni test (comparison between different groups). All values are presented as mean ± 
SEM. 
6.3 Results 
BOLD Signal Changes Correlate with the Thermal Stimulation Paradigm  
Thermal stimulation of the forepaws led to consistent BOLD responses in the S1 and S2 
somatosensory cortices and the thalamus. The signal changes correlated well with the 
stimulation pattern and intensity. The image and signal quality was high even when 
increasing the temporal resolution to 1 second.  
The maximal BOLD signal change at 45 °C was 2.8 ± 0.5 % in the S1 area contralateral to 
the stimulated paw and 1.8 ± 0.4 % in the thalamus. At 46 °C, the maximal BOLD signal 
changes in the contralateral S1 area were 4.4 ± 0.9 % and 4.1 ± 0.6 % for the laser spots of 2 
mm and 1 mm in diameter, respectively. The maximal BOLD signal changes in the thalamus 
were 3.3 ± 1.0 % (2 mm diameter) and 3.1 ± 0.6 % (1 mm diameter). The BOLD amplitude 
was influenced by the stimulation temperature, but not by the diameter of the laser spot (Fig. 
6-2b).  
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Figure 6-2: (a) Activation maps after left and right thermal forepaw stimulation of 45 and 46 °C. (b) 
Temporal BOLD profile of the somatosensory cortex (S1) contralateral to the stimulated paw. 
Stimulation parameters were: 46 °C, 1mm spot size (dark orange), 46 °C, 2mm spot size (red), and 45 
°C, 2mm spot size (light orange). Yellow blocks indicate stimulation periods. All values are given as 
mean + SEM.  
 
Nociceptive Block Induced by QX-314 and Capsaicin  
Combined application of the lidocaine derivative QX-314 and capsaicin led to a decreased 
BOLD activation detected in the brain (S1: 0.6 ± 0.3 %, p = 0.01; thalamus: 0.5 ± 0.2 %, p 
= 0.1) indicative of a specific inhibition of neuronal signal transmission via C-fibers. This 
inhibitory effect was not observed in the control experiments, where either compound was 
applied separately. Administration of QX-314 alone led to a maximal BOLD signal change 
of 4.9 ± 0.7 % in the S1, which was not significantly different from the untreated animals (p 
= 0.14) but significantly different from the combination treatment capsaicin plus QX-314 (p 
= 0.0002). Similar results have been found for the thalamic activation: the BOLD intensity 
of 4.0 ± 0.5 % was not different compared with untreated mice but significantly different 
(p=0.0001) from values obtained with the combination treatment. Application of capsaicin 
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alone led to maximal BOLD signal changes of 5.1 ± 0.8 % and 4.0 ± 0.7 % in the S1 and 
thalamus, which were both significantly larger than the corresponding values measured after 
combined treatment (p = 0.0002 and p = 0.0009, respectively). However, compared with the 
untreated animals, only the thalamus showed a significant increase (p = 0.02), while the S1 
area was not different (p = 0.08, p = 0.02; Fig. 6-3a).        
 
Figure 6-3: (a) Maximum BOLD signal changes of the S1 contralateral to the stimulated paw, and 
the thalamus. Pretreatment with QX-314 and capsaicin abolished the BOLD signal, while treatment 
with either substance alone did not decrease the BOLD signal change. All values are given as mean ± 
SEM. (b) Linear regression analysis of the BOLD signal changes in the thalamus and the S1yielded a 
correlation factor of R2 = 0.4836. 
 
When pooling all experimental results for untreated and treated animals, a relatively good 
correlation was found between the elicited BOLD signals of the S1 area and the thalamus. 
(R2=0.48, Fig 6-3b).  
The group analysis (Fig. 6-4) of all animals reflects the BOLD signal changes after thermal 
stimulation and treatment with QX-314 and/or capsaicin. The activity maps show the main 
activation appearing in the S1 area after stimulation of both paws at 45 °C (Fig. 6-4c). 
Pretreatment with QX-314 combined with capsaicin only led to some cortical activation in 
two of 14 scans (Fig. 6-4d). Pretreatment of either compound alone did not diminish the 
activation, but rather increased the activated areas in the brain (Fig. 6-4 e: QX-314, Fig. 6-4 
f: capsaicin).    
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Figure 6-4: (a) Mouse brain atlas (IAL +3.7 mm) with relevant regions (SI: primary somatosensory 
cortex, forepaw region; MI: primary motor cortex; CGC: cingulated cortex) overlaid on the 
anatomical MR-image. (b) Representative EPI image. (c-f) Activation maps after left and right 
thermal forepaw stimulation of 45 °C (c); (d) after pretreatment with QX-314 and capsaicin; (e) after 
pretreatment with QX-314; and (f) after pretreatment with capsaicin. Data show activated regions 
derived from GLM analysis (p = 0.001, cluster size 15 voxels) for all animals overlaid on the mouse 
brain atlas. The intensity indicates the number of animals showing significant BOLD activation at the 
given threshold. Scale bars are adjusted to the total number of scans performed for each experiment.  
 
6.4 Discussion 
fMRI has become an important and widely used tool in animal research, as it allows non-
invasive monitoring of brain functions in large brain volumes. Multiple studies in humans 
and in rodents have shown a good correspondence of the noxious-evoked activation patterns 
detected by fMRI and the network of the pain matrix [46, 97-101]. However, one has to 
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keep in mind that due to the hemodynamic nature of the signal, the activated areas may not 
be tightly confined to the functional brain structures but include areas covered by draining 
vessels. Therefore, the brain areas designated as being active from fMRI data extend beyond 
the structures as defined in the mouse brain atlas derived on the basis of electrophysiological 
results [103].  
In imaging in general and in fMRI in particular, there is a trade-off between sensitivity (i.e. 
signal-to-noise ratio, SNR), temporal resolution and spatial resolution. In this study we have 
optimized a protocol [46] to improve temporal resolution from 7.5 s to 1 s, while 
maintaining spatial resolution and only minimally compromising SNR in order to be 
sensitive enough to detect signal changes of only a few percents. Increasing the temporal 
resolution to 1 s is essential for better characterizing of the hemodynamic response and signal 
dynamics as a response to the stimulus.  
In contrast to electrical stimulation, thermal stimulation constitutes a physiological stimulus, 
which directly activates the nociceptive system. Temperature exceeding a threshold value is a 
noxious stimulus, which can be well controlled by adjusting several parameters such as the 
target temperature, spot diameter and stimulation duration. By choosing target temperatures 
of 45 or 46 °C, we predominantly induce TRPV1-mediated activation of the neural system. 
TRPV1 receptors are activated at temperatures of 42 °C and above, and the signal is 
transmitted via the unmyelinated C-fiber afferents [158]. Activation of the Aδ-afferents 
would occur by activation of the TRPV2 receptors, which have an activation threshold of 52 
°C [159], a temperature not reached with our stimulation paradigm. Temperatures should be 
kept below 50 °C to avoid any skin damage on the paw. In view of our relatively long 
stimulation period, skin damage might occur already at lower temperatures. Therefore all 
experiments were carried out at a temperature of 45 °C, a temperature leading to a robust 
BOLD signal change of 2.8 ± 0.5 % in the S1 area, which was considered sufficient for 
studying the pharmacological modulation of the response. Using these stimulation 
parameters, the animals were not injured and could be used for more than one experiment, 
an important prerequisite for longitudinal studies.  
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The temporal profile of the BOLD signal changes correlated well with the stimulation 
periods. The rise of the BOLD signal was slightly delayed with regard to the stimulus onset, 
which was due to the nature of the stimulus. The baseline temperature of the paw was usually 
around 31 °C and on average it took 20-25 seconds to reach the target temperature of 45 or 
46 °C at the paw. Since heat starts to be noxious at 42-43 °C, this was only reached a few 
seconds after stimulus onset, leading to brain activation as detected by BOLD measurements.  
The BOLD signal amplitude was influenced only by the target temperature, but not by the 
spot diameter. However, the signal shape appeared to be influenced by the spot diameter 
used. For the experiments performed with the 2 mm spot it seems that the signal decayed 
slower and did not return to baseline levels, indicating the presence of an underlying slower 
component as described earlier [46]. The temporal BOLD profile of the experiment carried 
out using the 1 mm spot shows faster signal decay in the initial phase after the stimulation, 
and the signal returns to baseline levels. All three profiles show fast signal decays during the 
first 20-30 s after stimulation, followed by a slower decay or stable signal, which might be 
due to hemodynamic effects. Another feature of the BOLD signal is the decrease in signal 
amplitude despite ongoing stimulation. This may be due to adaptation as has been shown for 
dorsal root ganglia cells, which show a slow decrease in activity over 2-3 s to continuous 
stimulation [161]. Another explanation may be the decaying vasodilatory signal which is 
subject to feedback regulation by CBF in response to a prolonged neuronal stimulus [77, 
113] and which has also been observed in experiments using electrical stimulation paradigms 
[46]. 
To verify the specificity of the BOLD signal readout, we pharmacologically modulated the 
nociceptive signal transmission. Binshtok et al. demonstrated in a recent study that the 
cationic lidocaine analogue QX-314 was able to enter neurons through opened TRPV1 
channels. Inside the cells, QX-314 blocks the sodium channels, thereby preventing the 
propagation of action potentials and inducing local anesthesia [167]. The opening of the 
TRPV1 channels can be achieved by applying capsaicin, a highly potent agonist. Since 
TRPV1 channels are only found on C-fiber afferents in the peripheral nervous system [158], 
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entering of QX-314 will cause a C-fiber specific nociceptive block. In contrast, neutral local 
anesthetics such as lidocaine can penetrate all fiber types and upon binding to sodium 
channels will lead to a transient sensory and motor inhibition [138, 139]. Since thermal 
stimulation predominantly activates C-fibers, we expected a significant decrease of the 
BOLD signal after application of QX-314 in combination with capsaicin. Indeed, the BOLD 
signal was almost totally abolished supporting the hypothesis that it reflects nociceptive 
processing in mice.  
The anesthetic properties of QX-314 are somewhat controversial. While several studies 
reported the compound not being able of passing the cell membrane and thus no anesthetic 
efficacy [163, 164, 167, 168], other studies claimed to have found an anesthetic effect of 
QX-314 comparable to that of lidocaine, but with a slower onset [169, 170]. They attribute 
the possible cell entry of the compound to the tonic activity of the TRPV1 channels [171], 
since application of the TRPV1 antagonist capsazepine prevents sensory blockade induced by 
QX-314 [169]. Our data demonstrating inhibition of nociceptive transmission by QX-314 
only in the presence of capsaicin, but not when administered a single compound, are rather 
in line with the hypothesis of the compound not penetrating neurons. 
The application of either substance separately did not lead to a decrease of the BOLD signal. 
In contrast, there was a trend towards an increase in the maximal signal amplitude. After 
capsaicin application this may be due to a sensitization effect since both capsaicin and 
noxious heat act on the same receptors. It has been shown that direct activation of the 
TRPV1 receptor may sensitize it to other stimuli [172]. The same may apply for the 
positively charged molecule QX-314, as a study by Ahern et al. has shown that cations 
directly gate and sensitize TRPV1 channels [173]. A transient reduction of thermal response 
latency in rats after injection of either 67 mM QX-314 or capsaicin (1.6 mM) has also been 
reported [167]. 
This study describes a robust and physiological stimulation paradigm to study noxious 
processing in mice non-invasively using BOLD fMRI. Reproducible activation has been 
observed in brain areas attributed to the pain matrix (S1 and S2, thalamus). The abolishment 
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of the signal after inhibition of nociceptive signaling demonstrates the specificity of the 
stimulation protocol and validates the BOLD readout as a response to noxious thermal 
stimulation. The method is non-invasive and therefore provides a tool for longitudinal 
studies of pain processing in normal and genetically engineered mice e.g. to investigate 
mechanism involved in hyperalgesia.   
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7. Conclusions and Outlook  
7.1 fMRI and Pain 
Pain is much more than just a transient unpleasant feeling after injury; it is a highly complex 
sensation involving somatosensory, emotional and psychological aspects. Acute nociceptive 
and inflammatory pain serves to guard the body from potentially damaging stimuli or to 
protect an injured site. The underlying mechanisms are quite well understood and pain is 
manageable by different types of analgesics. Chronic pain on the other hand is a serious 
health problem, which is a major cause of suffering and disability in our society. It does not 
serve a supportive function in the body, as it does not assist tissue repair or healing, but 
instead is caused by a malfunctioning somatosensory and nociceptive system. Neuropathic 
pain results from lesions to the peripheral or central nervous system, which induce alterations 
of nociceptive signal processing. This can lead to an enhancement of the response to a 
noxious stimulus (hyperalgesia), or to a pain sensation elicited by a normally innocuous 
stimulus (allodynia). Dysfunctional pain occurs in absence of any identifiable noxious 
stimuli, neural lesions or inflammation. Chronic pain can cause more disability and suffering 
than the original injury by which it was elicited. Long lasting changes of the nervous system, 
where complex interactions between ascending and descending branches of the 
somatosensory and pain conducting system take place, can lead to pain syndromes which 
persist long beyond the point of normal healing [174, 175]. Mechanisms underlying chronic 
pain, such as structural reorganization, central sensitization, disinhibition or neuro-immune 
reactions have been identified in recent years [176]. However, many still unresolved 
mechanisms together with complexly linked genetic, cellular and molecular components 
complicate the diagnosis and treatment of chronic pain. Much research is therefore 
conducted in this area, in order to develop treatment strategies for chronic pain patients.  
Functional imaging in humans and small animals is a promising tool to gain further insights 
into the mechanisms and pathologies of chronic pain. fMRI and PET studies of the human 
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brain and spinal cord have led to new knowledge of functional connectivity in pain pathways 
and of functional and structural changes occurring in chronic pain patients [177]. 
Application of whole brain imaging to small animals allows the translation from animal 
models to humans. However, in order to be able to explore the mechanisms underlying 
chronic pain, strategies to assess acute pain processing need to be implemented first, 
particularly when imaging animals, which are not able to articulate their sensations. In 
addition, one has to keep in mind that subjective and emotional symptoms associated with 
pain are too complex to be evaluated with animal models. Nevertheless, animal imaging is a 
tool of great potential in pain research, particularly in view of the increasing possibilities and 
techniques available to create genetically modified mouse models.  
Conventionally, sensory function in animals is assessed by behavioral tests that often measure 
reflex responses or innate behavior elicited by a stimulus. These tests have several drawbacks: 
they rely on intact motor function, the experimenter may be biased and the outcome 
measures reflex responses which are processed in spinal or supraspinal circuits, but do not 
involve cortical processing [178]. Functional imaging provides a method to objectively assess 
nociception which is used in animals and human studies and therefore allows performing 
comparable tests, at least to a certain extent. fMRI techniques are suitable to image the entire 
brain, including cortical and subcortical areas crucial for pain processing, resulting in a more 
thorough assessment of nociceptive processing as compared to the conventional behavioral 
tests. The use of a comparable method is an important prerequisite for translational research; 
nevertheless, there are still some restrictions to rodent fMRI which are mainly due to the 
small dimensions of the animals.   
Rat BOLD fMRI has been established for several years, leading to distinct activation patterns 
in the brain and spinal cord upon somatosensory or noxious stimulation. The activated brain 
areas are in good agreement with the areas belonging to the pain matrix, which was 
determined by functional imaging in humans [65, 66]. In contrast, mouse BOLD fMRI 
studies are still sparse despite the availability of numerous transgenic mouse models for pain 
research. The small dimensions of the mouse require high spatial resolution to display the 
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small brain areas. The main limiting factor is therefore the signal-to-noise (SNR) ratio for a 
given acquisition time. Increasing SNR can be achieved in several ways, one of them being 
the use of higher B0 fields. In addition to a strong magnetic field (9.4 T) a cryogenically 
cooled radiofrequency coil (CryoProbe) was used for all experiments of this thesis. Cooling 
the receiver electronics significantly reduces the noise in small animal imaging, leading to an 
increase of SNR. The application of the CryoProbe allowed for high spatial resolution in 
combination with relatively high temporal resolution, high SNR and comparably short 
acquisition times. Using this set-up, we were able to not only detect BOLD signal responses 
to peripheral stimulation, which are in the in the order of a few percent, but in addition we 
could modulate the stimulation and detect minute differences between BOLD responses to 
different peripheral inputs. EPI images, which are prone to distortion due to susceptibility 
artifacts, were acquired in a quality allowing precisely allocating the activated regions to a 
mouse brain template. The direct comparison to a room temperature coil of similar 
dimensions revealed a significant gain of SNR and a reduction of the variance of baseline 
signal. The gain in sensitivity allowed establishing a robust and sensitive BOLD readout at 
high spatial and temporal resolution in mice.  
7.2 Stimulation Paradigms 
An important aspect of this thesis was the establishment of robust stimulation paradigms. 
Electrical stimulation of either the forepaws or the hind paws is widely used in animal fMRI 
and induces robust activation in the brain. In our mouse studies, electrical stimulation at 
different amplitudes led to activation of brain areas considered to be part of the pain matrix: 
the somatosensory cortices S1 and S2, the thalamus and the insular cortex. Activation in all 
areas increased with increasing stimulation amplitude, and the BOLD signal change 
correlated with the stimulation periods. Despite the robust activation patterns elicited by 
electrical stimulation paradigm, there are also several drawbacks to it. Electrical stimulation is 
not physiological in the sense that it does not directly activate one of the body’s nociceptive 
systems (touch, heat, chemical) [161]. It is not quite clear what eventually induces the 
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activation: the current generates an innocuous or noxious sensation which is transmitted by 
the primary afferents. But electrical current can also directly activate neurons, the signal 
transmission of which is conveyed electrically along the axon. Therefore, subcutaneous 
electrical stimulation of the forepaw may activate all nerve fibers present in the paw, 
including motor fibers, leading to an unspecific brain activation originating from innocuous 
or noxious sensory, and antidromic motor signal transmission. A further point is the 
difficulty of discriminating noxious and innocuous stimuli. The stimulation strength depends 
on the current density, which is determined by the relative placement of the electrodes. This 
makes it difficult to compare stimulation parameters and their effect across different labs or 
with literature. A secure identification of the fiber types activated by electrical stimulation 
using different parameters could be obtained by electrophysiological recording of the 
different fiber types.  
In view of these restrictions we aimed at implementing a more physiological stimulation 
paradigm, using high temperatures to induce noxious stimulation. The advantages of laser 
stimulation as used in our studies are well controllable and reliable stimulus parameters, 
which can be adjusted in terms of intensity, duration, area and frequency. Thermo-sensing 
receptors are well described and temperature ranges of activation as well as the respective 
expression on primary afferents have been determined for different receptors. Thermal pain 
sensations are mediated by Aδ- and C-fibers, depending on the stimulation temperatures 
used [179, 180]. By stimulating at temperatures of 45-46 °C, predominantly TRPV1 
receptors located on C-fibers are activated, leading to a C-fiber-mediated noxious activation 
which is relayed to the brain via the spinothalamic tract. The two temperatures (45 and 46 
°C) applied in the studies of this thesis led to BOLD signal changes that correlated with the 
intensity of the stimulus. For stimulation at higher temperatures, the parameters of the 
stimulation paradigm would need to be adapted. The long stimulation period of one minute 
leads to a large deposition of heat, causing injuries at the affected paws when stimulated at 
temperatures around 50 °C, impeding longitudinal studies. The thermal stimulation 
paradigm proved to be a useful tool to investigate nociceptive processing in mice, which can 
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be applied to study the mechanisms involved in heat transmission and perception under 
normal and pathophysiological conditions.  
7.3 Anesthesia 
A crucial point that needs to be considered, also in view of translational studies, is the use of 
anesthetics in animal fMRI. In contrast to human fMRI studies where the subjects typically 
are conscious, most animal studies are performed on anesthetized animals in order to reduce 
motion artifacts and stress. Even smallest movements of the head will lead to image 
distortions and shifts in signal intensity which can be mistaken for stimulus-induced 
activation [181]. On the other hand, the imaging conditions (restraint, loud noise, enclosed 
space) are challenging for conscious animals and likely raise stress levels [81]. Despite these 
concerns, studies on fully conscious animals have been performed. Acclimation over a couple 
of days by restraining rats in a dark tube and playing pulse sequences seems to reduce stress 
levels in the animals as measured by heart rate, corticosterone levels, body temperature and 
movement. Comparing the data quality to non-acclimated rats, the contrast-to-noise (CNR) 
ratio is increased, probably by decreased physiological noise caused by motion, increased 
heart rate and respiration [81]. However, conscious rats, even if acclimated to the fMRI 
procedure, cannot be used for all fMRI paradigms. Noxious stimulation for instance, or any 
other stimulation which elicits a motor reflex, is not suitable as it would induce motion 
artifacts. Another possibility to perform studies on awake animals is to paralyze the animal 
using neuromuscular blocking agents, leaving the animal fully conscious but unable to move 
[83]. However, this requires artificial ventilation of the animal, which by itself is probably 
already quite stressful for a conscious animal and raises ethical issues about the experiment. 
Different restrainers or surgical interventions to implant a screw on the head are additional 
possibilities to perform fMRI on conscious animals [182-184], but the stress caused by the 
entire procedure is still a major concern. Primates such as marmosets or rhesus macaques can 
be well acclimated to the process without showing major stress syndromes [185, 186]. Still, 
mice, as used in our studies, are even more anxious and less controllable than rats, and 
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therefore probably almost impossible to acclimate to a scanning session without strongly 
restraining them. Any procedure necessary to perform fMRI on fully conscious mice would 
likely dramatically increase their stress levels, influencing the entire organisms and possibly 
affect the fMRI readout; potentially even more than under well controlled anesthetic 
conditions.   
Therefore, despite the effects of general anesthetics on neuronal metabolism, CBF, 
neurovascular coupling or sensory perception [82, 84, 187, 188] we chose to use the 
inhalation anesthetic isoflurane for our studies, in combination with paralysis of the mice. 
We reasoned that low concentrations of isoflurane will not influence the neurovascular 
coupling to an extent that would seriously interfere with the BOLD readout, but instead 
significantly reduce the stress and discomfort of the animal. This is particularly important in 
view of the noxious stimulation paradigms applied. The robust and sensitive BOLD signal 
changes observed confirm the suitability of the applied anesthesia protocols. 
7.4 Mouse Models of Pain 
The advent of transgenic techniques in the 1980’s that allowed altering the function or 
expression of a specific gene [189-191] has substantially affected pain research. Being able to 
study the role of individual genes and proteins promised to gain new insight into molecular 
mechanisms of pain, leading to the discovery of new drug targets. At present time, the Pain 
Genes Database [192] lists 322 genes published by MEDLINE/PubMed 
(www.pubmed.org), which have been analyzed using transgenic animals showing a pain-
related phenotype. Despite this vast number of pain- or nociception-related genes discovered, 
translation to humans and development of new effective and safe analgesics remains difficult 
[193]. The reasons for the limited success are complex and multilayered, one of them being 
the potential limitations of current animal models of pain. Animal models are important 
despite the well developed and reliable tools used for self-ratings of pain in human pain 
studies [194]. Animal models allow a less subjective assessment of the behaviors in response 
to a noxious stimulus; however, frequently the scored behavior shows a reflex or congenital 
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behavior, which lacks clinical validity [195]. Pain is a very complex phenomenon containing 
sensory and discriminative aspects that are largely processed separately from the motivational 
and affective characteristics [68, 196]. An ideal assay would consider all of these aspects in 
order to provide a translatable readout. Despite the numerous assays available and still being 
developed, none of them accounts for all dimensions of pain perception [197]. The use of 
transgenic animals in pain research holds great potential, but also some aspects which can 
complicate the interpretation of the results obtained. The most commonly used approach is 
generating null-mutant (knock-out) mice, where a specific gene is silenced by disrupting its 
sequence. The critical point lies in the absence of the gene already during development, 
inducing compensatory mechanisms which influence the phenotype, thereby masking the 
real changes due to the lack of the gene [198, 199]. To overcome these shortcomings, more 
advanced techniques allow to spatially and/or temporally control the gene disruption, 
allowing for more subtle interference with the organisms [200-203].  
The nociceptive specific NaV1.7 knock-out (NaV1.7R-/-) used for one of our studies in this 
thesis is an example of a conditional knock-out mouse where the gene SCN9A encoding for 
the voltage-gated sodium channel NaV1.7 is disrupted in nociceptors only [94]. Knocking-
out SCN9A globally leads to a lethal phenotype, most likely because the pups are unable to 
feed [204]. The NaV1.7R-/- in contrast are viable and show a loss of acute mechanical and 
inflammatory pain [94], which was reflected by a decrease of the BOLD response in our 
fMRI studies. Only a few years ago, humans suffering from a loss of function mutation of the 
SCN9A gene, which renders them insensitive to pain, were discovered [50], supporting the 
phenotype observed in the animals. On the other hand, human gain of function mutations of 
the SCN9A gene lead to a chronic inflammatory condition called erythermalgia [205]. 
Voltage-gated sodium channels are crucial for propagation of action potentials in neurons 
and hence in nociceptors. Mouse k.o.-studies have provided important knowledge about the 
genes coding for sodium channels [192], revealing three genes encoding for sodium channels 
only expressed on sensory neurons, presenting potential drug targets.  
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The other transgenic model used in our studies was a global cannabinoid receptor 1 knock-
out mouse (CB1-/-), which does not display any different spontaneous nociceptive thresholds 
as compared to WT mice [93]. This finding was corroborated by our fMRI experiment 
which did not show a difference of the BOLD response as compared to the WT animals, 
indicating that either the CB1 receptor does not play a critical role in processing of 
spontaneous nociception, or other systems compensate for the lack of the CB1 receptor. A 
recent study showed that global CB1-/- mice did not develop mechanical sensitization and 
secondary hyperalgesia induced by capsaicin as compared to WT or nociceptor-specific 
knock-out (sns-CB1-/-) mice [143]. The CB1-/- were used for our study based upon the 
supposition by Pernia-Andrade and colleagues, which showed a contribution of 
endocannabinoids and the CB1 receptor to heterosynaptic pain sensitization originating from 
the dorsal horn of the spinal cord [143]. The CB1-/- in our study indeed did not show the 
lidocaine-induced hyperalgesia observed in WT mice, a finding which could be reproduced 
by pretreatment of the WT mice with the selective CB1 -blocker rimonabant, reinforcing the 
results obtained with the transgenic animals.  
These examples display the potential of transgenic animals in revealing the functions of a 
certain gene or its role in a specific mechanism; however, they are not real pain models. 
Common clinical pain conditions are probably too polygenic and complex to be modeled by 
a (transgenic) animal [195].  
Another crucial point that needs to be considered in pain research is the differences resulting 
from factors such as mouse strain, sex, age and husbandry [206] [207, 208]. C57Bl/6 mice 
are popular subjects in research mainly due to their good performance in behavioral and 
cognitive tests [209, 210], but regarding nociception, they show higher sensitivity to 
nociceptive assays, are relatively resistant to developing thermal hyperalgesia and 
comparatively insensitive to a number of analgesic compounds as compared to other 
commonly used mouse strains [207].  
Hence, for a more thorough assessment of nociception in mice, a test not only measuring 
reflexes needs to be chosen, different strains should be compared, and mice of both sexes and 
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different ages should be used [195]. Of course, such study designs will likely increase inter-
subject variability and decrease statistical power, but the results obtained may be more 
suitable and meaningful for translational research.  
By using fMRI with peripheral noxious stimulation, we have a device to access cortical and 
subcortical processes involved in pain perception. To what extent emotional and associative 
aspects can be measured still needs to be determined, but in any case fMRI allows getting an 
overall picture of the brain areas activated upon a stimulus. Being non-invasive, fMRI also 
allows performing longitudinal studies, in which each animal can serve as its own control, 
and which enables to monitor functional and structural changes of the brain as a 
consequence of e.g. injury or chronic pain syndromes. Refinement of existing and 
development of new techniques will therefore likely render fMRI increasingly important in 
pain research, hopefully attributing to successful translational research.     
7.5 Outlook 
Electrical stimulation has been used for many studies in this thesis. Nevertheless, it is still not 
clearly determined which fiber types are activated upon stimulation, and thus at which point 
the stimulation turns from innocuous to noxious. Electrophysiological analysis of the 
activation of the distinct fiber types in response to electrical stimulation would therefore be of 
great value. Knowing the noxious threshold and involved fiber types would increase the 
significance of the stimulation paradigm for future studies, e.g. to directly compare 
innocuous and noxious stimulation.  
Thermal stimulation is an ideal tool to study normal or pathological nociception (e.g. heat 
hyperalgesia) in mice. Future applications could therefore lie in characterization of 
phenotyping of mouse models displaying different pathologies. For this purpose, the 
development of further stimulation paradigms would be of use, in order to assess the 
different forms of nociceptive input (temperature, chemicals, and touch). Complementary to 
heat stimulation, cold stimulation could be established, e.g. by injecting compounds 
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activating cold-sensing receptors, such as menthol or icilin [211], since cold allodynia 
(innocuous cool stimuli induce pain) is a major feature of neuropathic pain [212]. The 
development of an MR-compatible device for mechanical stimulation would allow for 
innocuous and noxious stimulation of pressure-sensitive sensory afferents. Application of 
different modalities would allow for a thorough and distinct characterization of mouse 
models as it is been done by conventional assays.  
Since the major health problem is chronic and not acute pain, this should become a major 
topic in animal fMRI research. Several mouse models to study chronic pain have been 
established, particularly to study neuropathic pain. Models for central neuropathic pain are 
mostly based on spinal cord injury; and a number of animal models have been developed to 
simulate human peripheral neuropathic pain, most of them based on injuries of or near the 
sciatic nerve [213]. Different approaches can be used for imaging of chronic pain syndromes. 
The stimulation paradigms implemented for the present work could be used to assess altered 
thresholds to acute innocuous or noxious stimuli (allodynia, hyperalgesia). In patients 
suffering from chronic pain, alterations of brain structures and functional connectivity have 
been reported [177]. The structural changes could be assessed by high-resolution fMRI of the 
brain to determine morphological alterations of brain structures and by using diffusion tensor 
imaging (DTI) [214], which allows to depict fiber tracts of the brain. Functional changes 
could be assessed using stimulus-induced fMRI, measuring changes in CBF, CBV or BOLD.    
Additionally, resting state fMRI could be established to assess default connection networks. 
Resting state fMRI has been applied to rats [215-217], but to our awareness not yet in mice. 
Technically, we should be able to implement it on the 9.4 T scanner using the CryoProbe, 
which significantly enhances sensitivity as measured by SNR [36]. Resting state fMRI applied 
to models of chronic pain syndromes may give new insights into alterations of functional 
connectivity and areas active in the absence of a stimulus. Correlation analyses used for 
evaluation of resting state activity could also be applied for stimulus-induced fMRI in order 
to assess functional connectivity of brain areas in correlation to a stimulus; a property which 
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might be changed as well in chronic pain states. Correlation analyses of functional networks 
may also be a way to assess the affective and emotional aspects of pain perception in mice.  
A last point which would be of great interest for pain research is the implementation of spinal 
cord fMRI in mice. Processes in the spinal cord are equally important in pain research as 
brain processes, as many pathological pain symptoms have their origin in the spinal cord. It 
would therefore be appealing to assess activity in the spinal cord elicited by peripheral 
stimulation. Rat spinal cord fMRI has been implemented [85-87, 218-221] but no studies in 
mice are, to our knowledge, published as yet. This may be due to two reasons complicating 
mouse fMRI: 1) The mouse spinal cord is small (1-2 mm); therefore the acquisition needs to 
be very sensitive combined with high spatial resolution and reasonable temporal resolution. 
However, even when recording with in-plane spatial resolution of 100 µm2, there will only be 
10-20 voxels across the spinal cord. 2) Physiological noise is greatly enhanced as compared to 
brain imaging, due to motion artifacts originating predominantly from respiration and heart 
beat. 3) The anatomical location of the spinal cord with its proximity to massive bone 
structures will cause susceptibility artifacts in T2*-weighted images. If these challenges can be 
overcome, mouse spinal cord fMRI could be a valuable tool to analyze nociceptive 
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